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Abstract 
Thousands of candidate human-specific genomic regulatory loci (HSGRL) have been identified, supporting the 
idea that unique to human phenotypes result from human-specific changes to genomic regulatory networks 
(GRNs). A notable common feature of HSGRL is a predominant location within non-protein coding sequences. 
A significant void is the lack of a genome-wide view on diverse families of HSGRL within the context of the 
principal regulatory structures of the interphase chromatin, namely topologically-associating domains (TADs) 
and specific sub-TAD structures termed super-enhancer domains (SEDs). Genome-wide proximity placement 
analysis of 10,598 HSGRL revealed that 0.8%-10.3% of TADs contain more than half of HSGRL. Of the 3,127 
TADs in the hESC genome, 24 (0.8%); 53 (1.7%); 259 (8.3%); and 322 (10.3%) harbor 1,110 (52.4%); 1,936 
(50.9%); 1,151 (59.6%); and 1,601 (58.3%) HSGRL sequences from four distinct families, respectively. TADs 
that are enriched for HSGRL and termed rapidly-evolving in humans TADs (revTADs) manifest distinct 
correlation patterns between HSGRL placements and recombination rates. There are significant enrichment 
within revTAD boundaries of hESC-enhancers, primate-specific CTCF-binding sites, human-specific RNAPII-
binding sites, hCONDELs, and H3K4me3 peaks with human-specific enrichment at TSS in prefrontal cortex 
neurons (p < 0.0001 in all instances). In hESC genome, 331 of 504 (66%) of SE-harboring TADs contain 
HSGRL and 68% of SEs co-localize with HSGRL, suggesting that HSGRL rewired SE-driven GRNs within 
revTADs by inserting novel and/or erasing existing regulatory sequences. Consequently, markedly distinct 
features of chromatin structures evolved in hESC compared to mouse: the SE quantity is 3-fold higher and the 
median SE size is significantly larger; concomitantly, the TAD number is increased by 42% while the median 
TAD size is decreased (p=9.11E-37). Present analyses revealed a global role for HSGRL in increasing both 
quantity and size of SEs and increasing the number and size reduction of TADs, which may facilitate a 
convergence of TAD and SED architectures of interphase chromatin and define a trend of increasing 
regulatory complexity during evolution of GRNs.  
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Introduction 
The genetic and molecular basis defining unique to human phenotypic features remains largely unknown. The 
near-comprehensive catalogue of changes within protein-coding genes that occurred during human evolution 
suggested that these changes alone cannot explain all unique to human traits (Chimpanzee Sequencing and 
Analysis Consortium, 2005; Green et al., 2010; Meyer et al., 2012; Prüfer et al., 2012; 2014; Fu et al., 2014), 
thus supporting the hypothesis that unique to human phenotypes result from human-specific changes to 
genomic regulatory sequences (King and Wilson, 1975).  
Extensive search for human-specific genomic regulatory loci (HSGRL) revealed thousands candidate 
HSGRL, a vast majority of which is residing within non-protein coding genomic regions (McLean et al., 2011; 
Shulha et al., 2012; Konopka et al., 2012; Capra et al., 2013; Marnetto et al., 2014; Glinsky, 2015). Candidate 
HSGRL comprise multiple distinct families of genomic regulatory elements, including regions of human-specific 
loss of conserved regulatory DNA termed hCONDEL (McLean et al., 2011); human-specific epigenetic 
regulatory marks consisting of H3K4me3 histone methylation signatures at transcription start sites in prefrontal 
neurons (Shulha et al., 2012); human-specific transcriptional genetic networks in the frontal lobe (Konopka et 
al., 2012); conserved in humans novel regulatory DNA sequences designated human accelerated regions, 
HARs (Capra et al., 2013); fixed human-specific regulatory regions, FHSRR (Marnetto et al., 2014); and 
human-specific transcription factor-binding sites, HSTFBS (Glinsky, 2015). Experimentally testable hypotheses 
on biogenesis and initial evidence of putative human-specific biological functions for several HSGRL families 
have been reported.  
Recent genome-wide computational meta-analysis of TFBS in human embryonic stem cells (hESC) 
demonstrated that transposable element-derived sequences, most notably LTR7/HERVH, LTR5_Hs, and 
L1HS, harbor thousands of candidate HSTFBS (Glinsky, 2015). A majority of these candidate HSGRL appears 
to function as TFBS for NANOG, POU5F1 (OCT4), and CTCF proteins exclusively in hESC, suggesting their 
critical regulatory role during the early-stage embryogenesis (Glinsky, 2015). Bioinformatics and proximity 
placement analyses revealed that hESC-specific NANOG-binding sites are enriched near the protein-coding 
genes regulating brain size, pluripotency long non-coding RNAs, hESC enhancers, and 5-
hydroxymethylcytosine-harboring sequences immediately adjacent to TFBS. Candidate human-specific TFBS 
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are placed near the coding genes associated with physiological development and functions of nervous and 
cardiovascular systems, embryonic development, behavior, as well as development of a diverse spectrum of 
pathological conditions such as cancer, diseases of cardiovascular and reproductive systems, metabolic 
diseases, multiple neurological and psychological disorders (Glinsky, 2015). 
Calculating as a baseline the evolutionary expected rate of base substitutions based on the 
experimentally determined level of conservation between multiple species at the given locus, the statistical 
significance of differences between the observed substitution rates on a lineage of interest in relation to the 
evolutionary expected rate of substitutions can be estimated. This method appears particularly effective for 
identifying highly conserved sequences within noncoding genomic regions that have experienced a marked 
increase of substitution rates on a particular lineage. It has been successfully applied to humans (Pollard et al. 
2006; Prabhakar et al. 2006; Bird et al. 2007), where the rapidly-evolving sequences that are highly conserved 
across mammals and have acquired many sequence changes in humans since divergence from chimpanzees 
were designated as human accelerated regions (HAR). Experimental analyses of HARs bioactivity revealed 
that some HARs function as non-coding RNA genes expressed during the neocortex development (Pollard et 
al. 2006) and human-specific developmental enhancers (Prabhakar et al. 2008). Consistent with the 
hypothesis that HARs function in human cells as regulatory sequences, most recent computational analyses 
and transgenic mouse experiments demonstrated that many HARs represent developmental enhancers (Capra 
et al., 2013).  
A notable void is the absence of a genome-wide integration of the rapidly emerging information on 
diverse families of candidate HSGRL within the context of the interphase chromosome structures defined by 
the breakthrough studies of interphase chromatin interactions and chromosome folding patterns in human and 
mouse cells. Recent pioneering work on the interphase chromosome structures revealed specific, reproducible 
folding patterns of the chromosome fibers into spatially-segregated domain-like segments. In the mammalian 
nucleus, beads on a string linear strands of interphase chromatin fibers are folded into continuous megabase-
sized topologically associating domains (TADs) that are readily detectable by the high-throughput analysis of 
interactions of chemically cross-linked chromatin (Dixon et al., 2012; Hou et al., 2012; Nora et al., 2012; Sexton 
et al., 2012).  It has been hypothesized that TADs represent spatially-segregated neighborhoods of high local 
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frequency of intrachromosomal contacts reflecting individual physical interactions between long-range 
enhancers and promoters of target genes in live cells (Dixon et al., 2012; Gorkin et al., 2014). Definition of 
TADs implies that neighboring TADs are separated by the sharp boundaries, across which the 
intrachromosomal contacts are relatively infrequent (Dixon et al., 2012; Gorkin et al., 2014).  
The identity of ESC critically depends on continuing actions of key master transcription factors (Young, 
2011; Ng and Surani, 2011), which govern the maintenance of the ESC’s pluripotency state by forming 
constitutively active super-enhancers (Hnisz et al., 2013; Whyte et al., 2013; Dowen et al., 2014). The most 
recent experiments show that regulation of pluripotency in ESC occurs within selected TADs by establishing 
specific sub-TAD structures, which are designed to isolate super-enhancers and target genes within insulated 
genomic neighborhoods and designated super-enhancer domains (Dowen et al., 2014). Super-enhancer 
domains (SEDs) are formed by the looping interactions between two CTCF-binding sites co-occupied by 
cohesin. In ESC, TADs and SEDs are designed to isolate super-enhancers (SEs) and target genes within 
insulated genomic neighborhoods to facilitate the precision of regulatory interactions between key genetic 
elements: SE, SE-driven cell identity genes and repressed genes encoding lineage-specifying developmental 
regulators (Dowen et al., 2014).  
In this contribution, genome-wide proximity placement analyses integrating data on 10,598 DNA 
sequences of individual regulatory elements comprising four distinct families of candidate HSGRL were 
performed within the context of the principal regulatory components of the interphase chromosome domain 
structures of the hESC genome. Results of the present analyses revealed mechanistic insights into structural-
functional features of HSGRL that may have contributed to the marked changes of the interphase chromatin 
structure, which are exemplified by the increased number and reduced size of TADs. Concomitant HSGRL-
associated increase of both the number and size of SEs points to the increasing regulatory complexity due to 
convergence of TAD and SED architectures as one of the main directions of the interphase chromatin 
structural changes during the evolution of genomic regulatory networks.  
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Results 
Identification of topologically-associating domains rapidly-evolving in the hESC genome 
Using genomic coordinates of 3,127 topologically-associating domains (TADs) in hESC (Dixon et al., 2012), a 
proximity placement analysis of 10,598 DNA sequences representing four distinct families of candidate human-
specific genomic regulatory loci (HSGRL) was performed (Table 1). The primary criterion for selection of this 
set of regulatory DNA sequences was the fact that they were identified in human cells lines and primary human 
tissues whose karyotype were defined as “normal”. Based on the origin and definition of corresponding 
HSGRL, the four HSGRL families were assigned the following designations:  
1) Human accelerated regions (HARs; Capra et al., 2013); 2) Human-specific transcription factor-binding sites 
(HSTFBS; Glinsky, 2015); 3) hESC-derived fixed human-specific regulatory regions (hESC-FHSRR; Marnetto 
et al., 2014); 4) DNase hypersensitive sites-derived fixed human-specific regulatory regions (DHS-FHSRR; 
Marnetto et al., 2014). The number of HSGRL placed within a given TAD was computed for every TAD in the 
hESC genome and the HSGRL placement enrichment was calculated as the ratio of observed values to 
expected values estimated from a random distribution model at the various cut-off thresholds (Table 1). 
Regardless of the chosen cut-off thresholds, placement of most HSGRL appears markedly restricted to the 
small fraction of TADs in the hESC genome (Table 1). Notably, a majority of individual sequences of each 
HSGRL family is placed within 0.8-10.3% of TADs in the human genome (Table 1). Of the 3,127 TADs in the 
hESC genome, 24 (0.8%); 53 (1.7%); 259 (8.3%); and 322 (10.3%) TADs are targeted by 1,110 (52.4%); 1,936 
(50.9%); 1,151 (59.6%); and 1,601 (58.3%) individual sequences assigned to DHS-FHSRR, HSTFBS, hESC-
FHSRR, and HAR families of HSGRL, respectively (Table 1). The genome-wide enrichment factors varied for 
different HSGRL families ranging from 6 to 16-fold for HARs; 7 to 17-fold for hESC-FHSRR; 30 to 45-fold for 
HSTFBS; and 43 to 88-fold for DHS-FHSRR (p < 0.0001 in all instances; Table 1). Based on these 
observations, TADs manifesting a statistically significant accumulation of HSGRL compared to the random 
distribution model were defined as the rapidly-evolving in humans TADs (revTADs).  
 
Follow-up analyses of the sixty revTADs enriched for placement of HARs and HSTFBS 
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Subsequent analyses were focused on the revTAD set harboring at least 10 individual regulatory DNA 
sequences assigned to either or both of two distinct HSGRL families: 2,745 human accelerated regions (HARs) 
and 3,803 human-specific transcription factor-binding sites (HSTFBS). The emergence of these two HSGRL 
families most likely is a result of different processes, because a vast majority of HSTFBS (99%) represented by 
human-specific sequences of regulatory DNA which are located within transposable elements (TE) - derived 
DNA segments (Glinsky, 2015), whereas HARs represent evolutionary highly conserved sequences that have 
experienced a marked increase of base substitution rates on a human lineage (Capra et al, 2015). A threshold 
of ten HSRGL per TAD was chosen for the revTAD selection based on a consideration that it would exceed 
~10-fold the expected placement number of individual HSGRL per TAD based on a random distribution model 
estimates.  
In the hESC genome, there are sixty TADs (1.9%) meeting these criteria (Table 2), 60% of which (36 
revTAD) harbor both HARs and HSTFBS (Supplemental Table 1). Notably, fifty of sixty revTADs (83%) 
assigned to this revTAD set harbor at least one HAR (Supplemental Table 1). Fourteen revTADs contain 
within their boundaries at least ten HARs and no HSTFBS, while ten revTADs harbor at least twelve HSTFBS 
and no HARs (Supplemental Table 1). Placement of both HARs and HSTFBS is markedly enriched in this set 
of revTADs, significantly exceeding the expected numbers for HARs (7.4-fold; p < 0.0001) and HSTFBS (18.8-
fold; p < 0.0001). Among HSTFBS, human-specific CTCF-binding sites manifest the most pronounced 
placement enrichment (28.4-fold; p < 0.0001).  
Next, the placement enrichment estimates were computed for multiple other genomic regulatory 
elements that were previously implicated as candidate regulatory loci with putative impact on human-specific 
phenotypes and were not considered during the revTAD selection process. Remarkably, placement of hESC 
enhancers, primate-specific CTCF-binding sites, human-specific RNAPII-binding sites, regions of human-
specific conserved deletions (hCONDELs), and H3K4me3 peaks with human-specific enrichment at 
transcription start sites (TSS) in prefrontal cortex neurons appears significantly enriched within the revTAD 
boundaries (p < 0.0001 in all instances; Table 2). Placement of H3K27ac peaks with human-specific 
enrichment in embryonic limb at E33 stage of human embryogenesis (Cotney et al., 2013) is significantly 
higher in the revTADs than expected by chance alone (Table 2). However, no increase of placements was 
 10 
 
observed for H3K27ac peaks with human-specific enrichment in embryonic limb at the later stages of 
embryogenesis, including E37; E41; and E44 stages (data not shown). These results seem to implicate the 
enhancers and promoters that are engaged during the first five weeks of human embryogenesis in limb 
development as putative targets for human-specific regulatory elements residing within the revTADs.  
One notable exception was the lack of significant placement enrichment for genes comprising human-
specific transcriptional genetic networks in the frontal lobe (Table 2), which were defined based on the 
analyses of adult brain tissues (Konopka et al., 2012). However, the FOXP2 gene encoding one of the principal 
transcription factors presumably contributing to the human-specific transcriptional control of these networks 
(Konopka et al., 2012) and previously implicated in evolution of human language and cognition, is residing 
within the revTAD harboring 12 HAR sequences, one human-specific NANOG-binding site, and 22 primate-
specific TFBS, including ten primate-specific CTCF-binding sites. Interestingly, the promoter of the FOXP1 
gene, which can form heterodimers with FOXP2 to regulate transcription and has been implicated in language 
impairment, intellectual disability, and autism, is also located within another revTAD harboring 10 HAR 
sequences and 17 primate-specific TFBS, including eight primate-specific CTCF-binding sites. One of the well-
known FOXP2 target genes, LMO4, is also located within yet another revTAD harboring 10 HAR sequences 
and 17 primate-specific TFBS, including seven primate-specific CTCF-binding sites. Several lines of 
experimental evidence strongly argue that LMO4 plays an important role in regulation of asymmetrically 
developed cognitive processes in humans such as language (Konopka et al., 2012). Nevertheless, the 
proximity placement analysis does not support the hypothesis that a majority of genes comprising human-
specific transcriptional networks in adult brain are located within revTAD regions of human genome. This 
conclusion is consistent with the previous observations that HSGRL are placed in close proximity to genes 
having important regulatory functions during the early embryogenesis (Glinsky, 2015).  
 
Correlation screens revealed distinct patterns of associations between individual members of HSGRL 
families residing within the revTADs 
At the next stage of the revTAD analysis, a series of correlation screens was performed to determine the 
relationships between the individual HSGRL residing within the revTAD boundaries (Figure 1). To this end, the 
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numbers of individual members of each HSGRL family and primate-specific TFBS located within the 
boundaries of each revTAD were calculated and corresponding correlation coefficients were computed. 
Notably, the placement patterns of HSTFBS and individual members of HSTFBS family manifested highly 
significant positive correlations with the number of primate-specific CTCF-binding sites located within the 
revTAD boundaries (Figure 1B). The most significant positive correlation coefficients were observed for 
human-specific TFBS and the weakest correlation was recorded for HSTFBS and non-human primate-specific 
CTCF-binding sites.  
In striking contrast, the significant inverse correlations were documented between the placement 
patterns of HARs and primate-specific CTCF-binding sites residing within the revTADs (Figure 1C). The most 
significant negative correlation coefficients were observed between the placement numbers of HARs and 
human-specific TFBS and the weakest inverse correlation was recorded between HARs and non-human 
primate-specific CTCF-binding sites.  
The results of these analyses suggest that placement and/or retention patterns of HARs and HSTFBS 
within the revTADs are guided and governed by distinct mechanisms. Placement and/or retention of HSTFBS 
appear to follow the CTCF-binding sites’ patterns, whereas locations of HARs seem to favor the revTAD 
regions harboring relatively fewer CTCF-binding sites resulting in highly significant inverse correlation between 
placement patterns of HARs and HSTFBS within the revTADs (Figure 1D).  
 
Distinct correlation profiles of HSGRL and recombination rates within the revTADs distinguish 
placement patterns of HARs and HSTFBS 
It has been reported that a prevalent mode of mutations in HARs is base substitutions that change weak (A, T) 
into strong (G, C) base pairs, which may occur during meiotic recombination as a result of a biochemical bias 
towards strong G/C alleles during the mismatch repair of heteroduplex DNA molecules (Kostka et al., 2012).  
Consistent with this notion, the enrichment of GC-biased substitutions of DNA sequences near recombination 
hotspots and a significant correlation between GC bias and recombination rate in the human genome have 
been reported (Katzman et al., 2011). Direct measurements of fine-scale recombination rates in genomic 
regions surrounding hominid accelerated conserved regions demonstrated significantly higher mean 
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recombination rate estimates for 30 Kb DNA segments around HARs (Freudenberg et al., 2007). These 
observations prompted detailed examination of recombination rates within the revTADs. Recombination rates 
were downloaded from the HapMap Project (The International Hapmap Consortium, 2007) and the number of 
DNA segments with the recombination rates of 10 cM/Mb or greater were identified for each revTAD. The 
results were plotted for visualization of spatial distributions (Figures 2A, B) and corresponding correlation 
coefficients were computed (Figures 2C, D). In these analyses, the total numbers of recombination hotspots 
having recombination rates of 10 cM/Mb or greater within boundaries of a given revTAD were determined and 
designated as the recombination scores (see Materials and Methods for details).  
Significant inverse correlations were observed between recombination scores and the numbers of 
HSTFBS residing within the revTADs (Figure 2C), whereas no significant correlation was recorded between 
recombination scores and non-human primate-specific CTCF-binding sites. In striking contrast with HSTFBS, a 
highly significant positive correlation was observed between recombination scores and the numbers HARs 
located within the revTADs (Figure 2D). Interactions of DNA strands are required for recombination process. 
Consistent with this notion, a significant positive correlation was recorded between the numbers of 
intrachromosomal contacts observed within a given revTAD region and the corresponding recombination 
scores (Figure 2D). This observation offers an opportunity to analyze the relationships between recombination 
rates and placement of distinct HSGRL in sub-groups of revTADs segregated based on the mean values of 
cumulative numbers of intrachromosomal contacts. Intrachromosomal contacts represent analytically and 
technically distinct set of variables, which has been measured genome-wide in entirely independent set of 
experiments by design, execution, and technical protocols (Jin et al., 2013). The strikingly distinct association 
profiles between recombination rates and placement patterns of either HARs or HSTFBS were documented 
when the mean values of corresponding variables were computed and analyzed for the revTAD sets, which 
were segregated into quartiles based on the cumulative values of numbers of intrachromosomal contacts 
observed within the regions (Figure 2D). The median recombination scores for the revTADs placed in the top 
quartile based on the quantity of observed intrachromosomal interactions was 40-fold greater compared to the 
median recombination score of the revTADs assigned to the bottom quartile (Figure 2D).  
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The results of these analyses are consistent with the hypothesis that placements of HARs and HSTFBS 
within the revTADs are associated with distinct molecular processes and support the idea connecting the 
biogenesis of HARs with high recombination rates. It has been demonstrated that HSTFBS are located almost 
exclusively within TE – derived DNA sequences (Glinsky, 2015), strongly implicating activity of TE in 
biogenesis of HSTFBS. Present observations of significant inverse correlations between the HSTFBS 
placement numbers and recombination rates within the revTADs are highly congruent with this hypothesis, 
because TE insertions are known to evade the genomic regions with high recombination rates (Rizzon et al., 
2002).  
 
Markedly distinct features of super-enhancers in the hESC genome compared with mESC 
The sustained expression of key cell identity genes and repression of genes encoding lineage-specifying 
developmental regulators is essential for maintaining ESC identity and pluripotency state. These processes are 
governed by the master TFs OCT4 (POU5F1), SOX2, and NANOG (OSN), that function by establishing SEs 
regulating cell identity genes, including master TFs themselves ((Hnisz et al., 2013; Whyte et al., 2013). The 
spatial relationships between SEs and HSGRL in the hESC genome within the context of TADs have not been 
investigated. To this end, the placement enrichment analysis was carried out to identify all TADs in hESC 
genome that harbor SEs and examine the association of SEs and HSGRL. There are 504 TADs (16%) 
harboring 642 SEs (94%) in the hESC genome. Remarkably, significant placement co-enrichments were 
observed between SEs, HSTFBS, and HARs residing within the boundaries of 279 TADs in the hESC genome 
(Table 3). In total, 279 TADs (8.9%) harbor 369 SEs (57.5%) that are co-localized with 300 HSTFBS and 564 
HARs. When other HSGRL families listed in the Table 1 were considered in co-localization analyses, 331 
TADs (10.6%) harboring 436 SEs (67.9%) were found to co-localize with HSGRL.  
In human genome, there are approximately 7,000 high-confidence hESC-enriched enhancers (Xie et 
al., 2013; Hnisz et al., 2013), less than 10% of which are defined as SEs (Hnisz et al., 2013). Placement of 
high-confidence hESC enhancers is significantly enriched within the revTADs (Table 2), implying possible 
genome-wide associations of HSGRL and hESC-enriched enhancers. Indeed, such associations became 
apparent when genomic co-localization analyses were performed to asses numbers of HSGRL and hESC-
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enriched enhancers residing within the boundaries of TADs. These analyses revealed that there is a significant 
direct correlation between the numbers of hESC-enriched enhancers and HARs that are located within the 
same revTADs (Figure 3). Genome-wide placement and/or retention of HARs appears enriched within hESC 
enhancer-harboring TADs and seems to favor TADs containing larger numbers of hESC-enriched enhancers 
(Figure 3).  
Co-localization of a majority of SEs with HSGRL suggest that HSGRL may affect the structural-
functional features of SEs in the hESC genome. Consistent with this hypothesis, genomes of human and 
mouse ESC manifest markedly distinct features associated with SE structures and functions. Despite strikingly 
similar genome sizes and numbers of protein-coding genes, hESC genome contains 3-fold more SEs 
compared to mouse: there are 684 SEs in the genome of hESC (Hnisz et al., 2013) and 231 SEs in the 
genome of mESC (Whyte et al., 2013). In the genome of hESC, only twenty-five of mESC SEs (11%) are 
represented as conserved orthologous sequences having genomic architecture of SEs, suggesting that 89% of 
mESC SEs lost the SE features in humans. Furthermore, 96% of SEs in the genome of hESC acquired 
structural-functional features of SEs during evolution after Euarchonta and Glires split 88 million years ago. 
The median size of SEs in hESC appears significantly larger compared to the median SE size in mESC ((9,589 
bp versus 8,667 bp, respectively; p = 0.017). Detailed size distribution analyses demonstrated that 
accumulation of SEs in hESC genome is associated with increased number of large SEs and decreased 
number of small SEs compared to mouse genome: there are 7-fold increase of very large SEs having size 
more than 30 Kb, consistent ~3-fold increase of SEs having size range from 2 – 30 Kb, and a marked 38-fold 
depletion of small SEs having size less than 2 Kb (Table 4; Figure 4).  
Collectively, these data indicate that structural-functional features of SEs are markedly distinct in the 
hESC genome compared to mouse, which appear associated with the enrichment of HSGRL within SE-
harboring TADs. It will be of interest to determine whether the HSGRL placement within SE-harboring TADs 
exerts biologically-meaningful effects on SE functions. Targeted placements and/or retention of HSGRL may 
increase density of enhancer elements within selected TADs, which would result in the merger of conventional 
enhancer units into super-enhancer structures containing the exceptionally high level of transcription-enabling 
apparatus to drive and continually maintain high expression of associated target genes. This idea is supported 
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by the findings that nearly 60% (1571) of the HARs overlap at least one of the common markers of enhancer 
activity in human cells (Capra et al., 2013).  
 
TAD structural features are markedly altered in the hESC genome compared with mESC 
There are 3,127 TADs in the hESC genome, which is 42% more than 2,200 TADs in the genome of mESC 
(Dixon et al., 2012). Coincidently, there are 87,883 CTCF-binding sites in hESC (Kunarso et al., 2010), 29,018 
(33%) of which represent primate-specific CTCF-binding sequences (Glinsky, 2015). The median size of TADs 
in hESC is significantly smaller compared to the median size of TADs in mESC (680 Kb versus 880 Kb; p = 
9.11E-37). Detailed size distribution analyses of TADs in human and mouse ESC (Figure 4; Table 5) revealed 
that there is a ~ 2-fold depletion of large TADs having size > 2,000 Kb and consistently increased numbers of 
medium-size and small TADs having size range from 100 - 1,000 Kb (Table 5). Structural-functional features of 
the revTADs in the hESC genome appear markedly distinct from the TADs of the orthologous sequences in the 
mouse ESC genome. Of the 60 revTAD listed in the Table 2, nineteen (32%) are placed within the primate-
specific sequences that failed to align to the mouse reference genome database sequence. Remaining 
revTADs appear to evolve by erasing the existing and establishing new domain boundaries within orthologous 
DNA sequences via two distinct mechanisms: 1) domain & boundary crossing (hESC TADs appear to cross 
boundaries of 2 to 4 orthologous TADs in mESC genome); and 2) domain shrinking & boundary creation 
(smaller hESC TADs are placed within the boundaries of larger orthologous TAD sequences in mESC 
genome).  
The above considerations prompted additional analyses of relationships between the SEs and TADs in 
the genomes of human and mouse ESC (Figure 5). These analyses revealed that in hESC there are 
significant direct correlations between the size of TADs and SE’s span defined as a number of bp between the 
two most distant SEs located within a given TAD (Figure 5A). Similar trends were observed in the mESC 
genome, however, the correlation coefficient values were not statistically significant. Correlation patterns 
observed for the 60 revTADs for placements of hESC-enriched enhancers, HARs, HSTFBS, and size of TADs 
were validated on a larger set of 147 revTADs (Figure 5B). Genome-wide, the highly significant direct 
correlation was discovered between the size of TADs and the number of hESC-enriched enhancers located 
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within TADs (Figure 5C). These observations are conceptually coherent because TAD boundaries were 
inferred from the relative prevalence and directionality of interchromosomal interactions along the chromosome 
length (Dixon et al., 2012), which are predominantly mediated by the enhancers’ activities and detected as 
enhancer-promoter and enhancer-enhancer interactions in the Hi-C analyses. It will be of interest to determine 
experimentally whether the size and boundaries of the adjacent and neighboring TADs can be altered by 
increasing the density, structure, and activity of the resident enhancers.  
 
Potential mechanisms of HSGRL-mediated effects on principal regulatory structures of interphase 
chromatin 
Present analyses provide a conceptual framework for understanding genome-scale regulatory changes during 
evolution within the context of the principal regulatory structures of the interphase chromatin to reflect an 
apparent trend toward increasing complexity of genomic regulatory networks (Figure 6). Experimental 
observations at the foundation of building blocks of the genome’s evolution model (GEM) are presented in the 
previous sections and additional considerations are focused on the analyses of potential contributions of SEs 
and hESC-enriched enhancers to these processes. 
 According to GEM, one of the key elements of the evolution of genomic regulatory networks is the 
creation of new enhancer elements (Figure 6). Conventional enhancers comprise discrete DNA segments 
occupying a few hundred base pairs of the linear DNA sequence and harboring multiple TFBS. SEs consist of 
clusters of conventional enhancers that are densely occupied by the master transcription factors and Mediator 
(Whyte et al., 2013). Therefore, it is logical to expect that creation of new TFBS and increasing density of 
TFBS would increase the probability of the emergence of new enhancer elements. Creation of new enhancers 
and increasing their density would facilitate the emergence of new SE structures. This sequence of events 
would imply that evolutionary time periods required for creation of TFBS, enhancers, and SEs are shortest for 
TFBS, intermediate for enhancers, and longest for SEs. To test this assumption, estimates of creation time 
periods for enhancers and SEs in the hESC genome were calculated (Table 6) and compared to the estimates 
of creation rates of TFBS (Glinsky, 2015). Consistent with the model expectations, the estimated creation time 
is markedly longer for SEs compared to enhancers for conserved (8-fold), primate-specific (17-fold), and 
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human-specific (63-fold) regulatory sequences (Table 6). Furthermore, the estimated creation time periods for 
enhancers appear several fold longer compared to the creation time estimates for TFBS sequences in both 
chimpanzee and humans (Glinsky, 2015). One of the intriguing results of this analysis is that 87% of new SEs 
and 75% of new enhancers in the hESC genome were created within conserved sequences (Table 6). 
Similarly, a majority (67%) of new binding sites for NANOG (59,221 of 88,351 TFBS) and CTCF (58,865 of 
87,883 TFBS) proteins in the hESC genome compared with mESC are located within conserved sequences 
(Supplemental Figure S3).  
Notably, the estimated creation time appears accelerated in humans compared to chimpanzee for both 
SEs (7-fold) and enhancers (27-fold), suggesting that human genomes were acquiring new regulatory 
elements and increasing the regulatory complexity and precision of genomic regulatory networks at the 
markedly accelerated pace.  
 CTCF-binding sites play a crucial role in defining the TAD boundaries (Dixon et al., 2012; Li et al., 
2013) and in establishing the SED architecture (Dowen et al., 2014). Knocking down the expression of CTCF 
and cohesin genes to reduce their protein concentrations results in a decrease in the number of intra-TAD 
chromatin loops (Sofueva et al., 2013; Seitan et al., 2013; Zuin et al., 2014), increase in the number of inter-
TAD chromatin interactions crossing the TAD boundaries (Zuin et al., 2014), and chromatin compaction (Tark-
Dame et al., 2014). Several lines of evidence are in agreement with the hypothesis that creation of new CTCF-
binding sites may have contributed to the rewiring of genomic regulatory networks during primate evolution: 
i) In the hESC genome, 29,018 of 87,883 (33%) CTCF-binding sites represent primate-specific 
sequences (Kunarso et al., 2010; Glinsky, 2015); 
ii) Of the 23,709 constitutive CTCF-binding sites implicated in defining TAD boundaries in the human 
genome (Li et al., 2013), 6,787 sites  (28.6%) failed alignment to the mouse genome, suggesting 
that they represent primate-specific sequences;  
iii) Two hundred eighty seven HARs (10.5%) are located within 10 Kb of the 336 constitutive CTCF-
binding sites; 
iv) Five hundred seventy one HARs (20.8%) are located within 1 Kb of 953 CTCF-binding sites; 
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v) Activation of retrotransposons and lineage-specific repeat-driven dispersion of CTCF-binding sites 
has produced species-specific expansions of CTCF binding in mammalian genomes and these new 
CTCF-binding sites function as chromatin domain insulators and transcriptional regulators (Schmidt 
et al., 2012).  
Detailed proximity placement and HAR/TFBS co-localization analyses identified 123 HARs located 
within 1 Kb from 127 high-confidence CTCF-binding sites, which were validated in 23 different human cells 
lines. Notably, 123 of 127 (97%) high-confidence CTCF-binding sites represent overlapping CTCF/RAD21-
binding sites, which is consistent with their putative regulatory role in establishing TAD boundaries and/or SED 
architecture. A significant majority of 123 HARs located near high-confidence overlapping CTCF/RAD21-
binding sites harbor at least one TFBS in human cells (76 HARs; 62%).  
Significant increase of TAD and SED numbers in human genomes compared with mouse indicates that 
chromatin folding profiles are dramatically altered, reflecting more frequent intrachromosomal segmentation of 
linear DNA fibers and enhanced likelihoods of formation of isolated intra-segmental looping structures. These 
changes of chromatin folding profiles and DNA fibers’ packaging patterns would impose more stringent 
requirement on DNA elasticity, particularly, near the TAD and SED boundaries due to bending of DNA double 
helix. Consequently, changes of DNA sequence and/or chromatin structure may be necessary to 
accommodate these new structural requirements. It has been reported that SINE repeats are enriched at the 
TAD boundaries (Dixon et al., 2012), suggesting that insertion of repetitive elements may contribute to 
changes of DNA elasticity near putative bending sites. Consistent with this hypothesis, a survey of SED 
sequences in hESC revealed a systematic significant enrichment of Alu elements within ~5 Kb windows near 
SED boundaries (Figure 7). Clusters of closely-spaced sequences of at least three Alu elements belonging to 
most ancient AluJ (~65 million years old), second oldest AluS (~30 million years old), and currently active 
modern AluY sub-families (Bennett et al., 2008) were observed frequently, suggesting that placement and/or 
retention of Alu elements at these sites were occurring for millions of years and continues at the present time. 
Taken together with the recent report that nearly 60% of the HARs overlap at least one of the common 
markers of enhancers in human cells (Capra et al., 2013), these observations strongly argue that creation of 
new enhancer elements is one of the key events defining evolution of genomic regulatory networks. Marked 
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acceleration of the TFBS and enhancers’ creation processes in humans may have contributed to genome-
scale rearrangements of principal regulatory structures of the interphase chromatin, leading to the increased 
complexity and enhanced precision of genomic regulatory networks and emergence of human-specific 
phenotypes. Frequent locations of Alu sequences near the putative DNA bending sites suggest their potential 
role in regulation of the elasticity of chromatin fibers by reducing nucleosome placements due to the low affinity 
of Alu elements to nucleosome binding (Huda et al., 2009) and/or facilitating strand invasion reactions between 
neighboring DNA strands leading to Alu/Alu recombination events (Lee at al., 2015; Morales et al., 2015). This 
model is in agreement with the observations that Alu elements appear preferentially retained in GC-rich and 
gene-rich regions of the human genome (Lander et al., 2001).  
 
Conservation patterns of HSGRL in individual human genomes 
All analyses conducted so far were performed using the reference genome databases and not the individual 
human genomes. To address this limitation, the assessment of conservation of HSGRL in individual genomes 
of 3 Neanderthals, 12 Modern Humans, and the 41,000-year old Denisovan genome (Reich et al., 2010; Meyer 
et al., 2012) was carried-out by direct comparisons of corresponding sequences retrieved from individual 
genomes and the human genome reference database (http://genome.ucsc.edu/Neandertal/ ). Full-length 
sequence alignments with no gaps of the individual genome sequences to the corresponding sequences in the 
human genome reference databases of both hg18 and hg19 releases were accepted as the evidence of 
sequence conservation in the individual human genome.  
Sequences of all analyzed to date HSGRL appear conserved in individual human genomes (Figure 8 
and Supplemental Figure S4), albeit a significant inter-individual variability in degree of conservations of 
specific HSGRL is apparent. Conservation of all HSGRL are consistently at the lowest level in the 
Neanderthals’ genome, suggesting that creation and/or retention rates of HSGRL are enhanced in Modern 
Humans. The results of these analyses indicate that sequences of HSGRL with assigned biochemical 
functions, e.g., specific TFBS or Lamin B1 (LMNB1)-binding sites, which are residing within HARs exhibit 
markedly higher conservation levels compared to sequences of HARs harboring the corresponding HSGRL. 
This conclusion remains valid for HSGRL sequences with assigned specific biochemical or biological functions 
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that were associated with HARs by proximity placement analyses (Figure 8A, B). HSGRL sequences 
manifesting the relatively high conservation levels in the Neanderthals’ genome appear most conserved in the 
individual genomes of Modern Humans as well, including the 41,000-year old Denisovan genome (Figure 8B).  
Consistent patterns of significant direct correlations between conservation profiles of distinct seemingly 
unrelated HSGRL sequences in individual human genomes were observed (Figure 8C and Supplemental 
Figure S4). One possible interpretation of these observations is that HSGRL conservation patterns reflect 
intrinsic features of the individual human genome, integration of which can gauge the overall capacity of a 
genome to create and retain HSGRL. This idea was tested by calculating for each individual human genome 
the genomic fitness scores integrating into a single numerical value sequence conservation data of 909 
HSGRL (Figure 8D). Notably, individual human genomes appear markedly distinct based on the results of this 
analysis with the lowest genomic fitness score of 0.9 in Neanderthals, followed by the scores of 1.89; 2.22; and 
2.27 for individual genomes of Native American, Denisova cave, and Mongolian subjects, respectively. On the 
other end of the spectrum, the genomic fitness scores of 4.51; 4.72; and 4.73 were obtained for genomes of 
Yoruba (West Africa), French (Western Europe), and San (Southern Africa) individuals, respectively.  
These observations are highly congruent with the recent definition of structural variations-free (fixed) 
human-specific regulatory regions (FHSRR) based on the stringent formal analysis of the HSGRL intra-species 
patterns of variations within human population using exome and full genome sequencing database of 1,092 
individuals from the 1000 Genomes Project Consortium (Abecasis et al., 2012; Marnetto et al., 2014). 
Collectively, the consistent evidence of HSGRL conservation in individual human genomes are in accord with 
the hypothesis of their putative functional role in defining human-specific phenotypes.  
 
Working models of NANOG, POU5F1, and POU3F2 super-enhancers’ domains in hESC 
One of the potential practical utilities of the outlined concepts is the opportunity to use the available genomic 
information for building the experimentally testable working models of SEDs and TADs, which may be suitable 
for precise molecular and genetic definitions of critical structural elements of human-specific regulatory 
networks. To test this notion, the GEM principles (Figure 6) were utilized as a blueprint to build working 
models of NANOG, POU5F1, and POU3F2 super-enhancers’ (SEDs) domains in hESC (Figure 9; 
 21 
 
Supplemental Figure S5) and compare them to the corresponding SED structures recently identified in the 
mESC genomes (Dowen et al., 2014).  
 To identify the putative SED boundaries, a systematic search was conducted for nearest overlapping 
CTCF/cohesin sites located next to borders of the two NANOG super-enhancers (Hnisz, et al., 2013). One of 
the notable features of the human NANOG SED is the presence of a large primate-specific region, which 
places the down-stream NANOG SED boundary within lamina-associated domain (LAD) harboring the primate-
specific overlapping CTCF/cohesin site (Figure 9A). Modeling of the human NANOG SED reveals that there 
are at least three possible designs of SED architecture that would incorporate both the NANOG SE and the 
target gene NANOG within the isolated genomic neighborhood of the looping structure formed as a result of 
interactions between two overlapping CTCF/cohesin sites (Figure 9A). Two of SED design variants would 
include only one NANOG SE and would require the interactions between the primate-specific and conserved 
overlapping CTCF/cohesin sites enabling formation of the isolated genomic neighborhood loops of relatively 
smaller sizes (Figure 9A; Supplemental Figure S5). The largest NANOG SED looping structure would result 
from interactions between two primate-specific overlapping CTCF/cohesin sites and it would incorporate both 
NANOG SEs within SED (Figure 9A). Notably, the postulated NANOG SED sequence harbors five primate-
specific NANOG-binding sites previously identified in the hESC genome (Kunarso et al., 2010; Glinsky, 2015), 
which may indicate that NANOG protein exerts more efficient control over its own locus in primates’ genomes. 
In the mESC genome, the NANOG SED is markedly smaller occupying just 52 Kb and harboring only a single 
NANOG SE (Dowen et al., 2013). The entire SED region down-stream of the NANOG gene, which contain the 
NANOG SE sequence, has no orthologous sequences in primate and human genomes and appears replaced 
by the large primate-specific sequence in the human genome (Figure 9A; Supplemental Figure S5).  
 Similarly dramatic rearrangements of the SED architecture in the hESC genome are apparent when 
additional examples of the SED structures insulating SEs regulating POU5F1 and POU3F2 target genes were 
analyzed (Figure 9B; Supplemental Figure S5). In all instances, the genomic looping structure-enabling 
interactions between two overlapping CTCF/cohesin sites would require the involvement of at least one 
primate-specific overlapping CTCF/cohesin-binding site. The POU5F1 SED region harbors one human-specific 
and three primate-specific NANOG-binding sites (Figure 9B; Supplemental Figure S5), whereas the POU3F2 
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SED contains ten hESC-enhancers and twenty-eight primate-specific TFBS for NANOG (15 sites), POU5F1 (6 
sites), and CTCF (7 sites) proteins (Supplemental Figure S5).  The example of POU3F2 SED is of particular 
interest because it is located within one of the rapidly-evolving in humans TADs and, according to recent 
experiments, the POU3F2 gene plays a pivotal role in the highly efficient conversion of human pluripotent stem 
cells as well as non-neural human somatic cells into functional neurons (Pang et al., 2011; Wapinski et al., 
2013). Of note, sequences near the overlapping CTCF/cohesin sites, interactions between which bring about 
the SED structures, appear to have a common structural element comprising two conserved in individual 
human genomes LMNB1-binding sites adjacent to CTCF/cohesin sites (Figure 9C; Supplemental Figure S5). 
These LMNB1-binding sites may serve as anchors to nuclear lamina for DNA sequences harboring the 
overlapping CTCF/cohesin sites, thus thermodynamically enhancing the likelihood of creation and/or stabilizing 
the maintenance of the base of SED structures.  
 Applying the GEM principles (Figure 6) as a guidance to infer the putative SED and TAD structures, it 
is possible to build the working models of the multidimensional chromatin architecture for large genomic 
regions spanning 2.54-3.26 Mb and containing 3-4 TAD structures (Figures 10 & 11; Supplemental Figure 
S6). Key elements of this design strategy entails the following considerations:  
i) Defining the positions of SED bases by the overlapping CTCF/cohesin sites interacting with each 
other to create the SED structure;  
ii) Mapping the putative bending sites of linear chromatin fibers based on the positions of Alu clusters 
near the overlapping CTCF/cohesin sites;  
iii) Requiring that SEs and their target genes are located within the same insulated chromatin looping 
structure;  
iv) Taking into account the relative strength of the chromatin fiber interactions with nuclear lamina 
based on placements of corresponding DNA sequences within or outside LADs and/or based on the 
quantity of LMNB1-binding sites within a region;  
v) Strictly adhering to the previously defined genomic positions of TAD and LAD boundaries, ESC 
enhancers, primate-specific TFBS, and HSGRLs.  
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Using this strategy, a model has been built representing a global view of multidimensional chromatin folding 
patterns within the 2.54 Mb genomic region containing the NANOG-residing TAD and two adjacent neighboring 
TADs (Figure 10).  A more detailed depiction of sequential steps of the model building is presented in the 
Supplemental Figure S6. It seems evident, that one of the principal structural elements defining directionality 
of the NANOG SED looping structure in the human genome is the insertion immediately downstream of the 
NANOG gene of the primate-specific sequence, which is tightly attached to the nuclear lamina as depicted in 
the Figure 10 by placement of the corresponding part of the NANOG SED within red-colored LAD. The 
remaining part of the NANOG-harboring TAD represents the genomic region located upstream of the NANOG 
SED. It is not attached to the nuclear lamina and contains the SLC2A3 SED, which is located in its entirety 
outside of the LAD boundaries (Figure10). Further upstream of the SLC2A3 SED at the boundary region 
between the NANOG-harboring TAD and adjacent upstream TAD, the chromatin fiber re-attaches to nuclear 
lamina and places within LAD the entire TAD containing 4-5 insulated neighborhood looping structures (Figure 
10). It will be of interest to determine how transitions of placements of chromatin fibers between positions 
within and outside LAD would affect the creation of SED structures and performance of insulated within SED 
genomic regulatory circuitry. One of the near-term practical applications of this approach to multidimensional 
modeling of SED and TAD structures became apparent when the regulatory elements residing within 
corresponding TADs and sub-TAD structures were catalogued and reviewed.  
 
Conserved profiles and uniquely distinct patterns of H3K27ac peaks’ distribution within the NANOG-
associated genomic region in 43 types of human cells and tissues 
One of the characteristic regulatory features systematically associated with hESC enhancers located within 
four TADs of the NANOG region is the presence of multiple binding sites for both EP300 histone 
acetyltransferase and histone deacetylase 2, HDAC2 (Figures 10 & 11; Supplemental Figure S6). Both 
histone acetyltransferases (HATs) and histone deacetylases (HDACs) have essential and pleiotropic roles in 
regulation of stem cell self-renewal by maintaining expression of master TFs regulating the pluripotent state 
and controlling the core transcriptional regulatory networks of embryonic stem cells and their differentiated 
progenies (Chen et al., 2008; Fazzio et al., 2008; Zhong X, Jin Y, 2009; Li et al., 2012; Jamaladdin et al., 
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2014). These observations are likely reflect the requirement for constitutive activities of both HATs and HDACs 
at transcriptionally active regulatory elements, because nucleosome maintenance and turnover are highly 
dynamic at these loci due to markedly accelerated exchange rates of histones, which appear directly 
associated with the histone modifications defining the active chromatin regulatory state. For example, H3.3-
containing nucleosomes undergo rapid turnover at active enhancers and promoters (Kraushaar et al., 2013). 
This fast turnover is positively correlated with active chromatin histone modification marks, including H3K4me1, 
H3K4me3, H3K9ac, and H3K27ac (Kraushaar et al., 2013). In contrast, the nucleosome exchange rate is 
negatively correlated with repressive chromatin marks H3K27me3 and H3K9me2 at regulatory loci and 
H3K36me3 modifications within gene bodies (Kraushaar et al., 2013).  
It is intriguing that binding sites for HDAC2 but not HDAC1 were detected in this region. Of note, it has 
been demonstrated that a single allele of Hdac2 but not Hdac1 is sufficient to rescue normal mouse brain 
development in double knockout Hdac1−/−Hdac2−/− mice and that HDAC2 has a unique indispensable role in 
controlling the fate of neural progenitor cells (Hagelkruys et al., 2014). Forced neuron-specific overexpression 
of HDAC2, but not HDAC1, reduced dendritic spine density, synapse number, synaptic plasticity, and memory 
formation in mice (Guan et al., 2009). Consistently, reduction of synapse number and learning impairment of 
Hdac2-overexpressing mice were ameliorated by chronic HDACi treatment (Guan et al., 2009). In the mouse 
models of neurodegeneration and in brains of patients with Alzheimer’s disease, cognitive capacities were 
severely impaired by the epigenetic blockade of gene transcription at specific genetic loci important for learning 
and memory, which is mediated by the increased HDAC2 activity at these sites (Gräff et al., 2012). 
Neurodegeneration-associated memory impairments, abnormal structural and synaptic plasticity, and 
diminished expression of genes regulating learning and memory were reversed following shRNA-mediated 
knockdown of HDAC2 overexpression (Gräff et al., 2012). Critical role of HDAC2 in regulation of brain 
functions is supported by the recent experiments on individual neurons demonstrating that HDAC2 cell 
autonomously suppresses excitatory activity and enhances inhibitory synaptic function in CA1 pyramidal 
neurons (Hanson et al., 2013).  
Since SE structures in genomes of human cells were defined based on the genomic profiles of H3K27ac 
peaks (Hnisz et al., 2013), it is reasonable to argue that patterns of SE placements within TAD reflect genomic 
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positions of H3K27ac peaks and should faithfully represent the snap-shot of the balance of continuing HAT and 
HDAC activities at specific regulatory sites within a region. Based on these considerations, genomic maps of 
SE distributions were drawn for 43 distinct types of human cells and tissues by retrieving genomic coordinates 
of SEs from the recently reported comprehensive catalogue of SEs in human body (Hnisz et al., 2013). 
Regional genomic maps of SE distributions shown in Figure 11 depict numbers of SEs placed within 3.26 Mb 
genomic region containing four TADs and three TAD boundaries for individual types of human cells and tissues 
against the background of SE distribution profiles within the same region in the hESC genome. It is evident that 
all individual profiles of SE distributions in human cells and tissues, which reflect distribution profiles of 
H3K27ac peaks, follow the general pattern of SE distributions established in the hESC genome (Figures 11B 
& 11C). One of the notable common elements that emerged in many differentiated cells and tissues is the 
appearance of SEs within the genomic regions demarcating TAD boundaries in the hESC genome, suggesting 
that TAD boundaries and TAD structures underwent visible rearrangements in humans’ differentiated cells and 
tissues compared with hESC. Erasing the hESC TAD boundaries during differentiation due to appearance of 
new cell-type specific SEs is consistent with observed decreasing numbers of TADs in differentiated cells and 
tissues (Figure 4).  
Transformation of these data into different types of charts for patterns’ visualization (Figures 11B-E) 
revealed that all analyzed human cells and tissues manifest unique profiles of SE/H3K27ac distributions within 
the 3.26 Mb NANOG-associated genomic region. It seems quite remarkable that quantitative distribution 
profiles of the very small set of markers located within ~0.1% of human genome appear to distinguish 43 
distinct types of human cells and tissues. This notion is best illustrated in the Figure 11E showing the data set 
of 43 distinct types of human cells and tissues that were sorted in descending order based on total numbers of 
SEs located within the 3.26 Mb NANOG-associated genomic region. It is clearly visible that most samples are 
easily distinguishable by the total number of SEs located within the region and samples that have the same 
numbers of SE’s manifest readily distinct SE/H3K27ac distribution profiles (Figure 11E). These results seem to 
point to a stochastic, i.e., random and probabilistic, nature of the underlying causal mechanisms driving the 
emergence of unique profiles of SE/H3K27ac distributions in differentiated cells and tissues from the singular 
parental SE/H3K27ac distribution profile in hESC. Consistent with this hypothesis, 45.2% of human cells’ and 
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tissues’ samples have the higher numbers of SE’s placements compared with hESC, whereas the SE’s 
placement numbers are lower compared with hESC in 54.7% of samples (Figure 11E).  Collectively, this 
analysis appears to indicate that the emergence of unique cell type-specific patterns of SE/H3K27ac 
placements may have been triggered by the small bidirectional changes of the balance between the HAT’s and 
HDAC’s activities in the genome of hESC that evolved during the differentiation process into arrays of 
quantitatively distinct patterns of SE/H3K27ac distributions in different types of cells and tissues in human 
body.  
 
Putative regulatory consequences of targeted placements of HSGRL affecting expression of protein-
coding genes 
Observed increasing regulatory complexity in human genomes associated with targeted placements of HSGRL 
is consistent with a view that increasing genomic complexity within fixed environments represents a major 
evolutionary trend in the natural world (Adami et al., 2000). Further analysis suggests that these changes of 
nuclear regulatory architecture may facilitate the enhanced precision of regulatory interactions between 
enhancers and target genes within insulated neighborhoods of chromatin regulatory networks. The boundaries 
of a majority of TADs are shared by the different cell types within an organism, segregating genomes into 
distinct regulatory units that harbor approximately seven protein-coding genes per TAD (Dixon et al., 2012; 
Smallwood and Ren, 2013). In contrast, nearly two-third of revTADs (39 of 60 revTADs; 65%) contain five or 
less protein-coding genes. Among these, eight revTADs harbor just one protein-coding gene and two revTADs 
contain only non-coding RNA genes. Of the twenty one revTADs harboring more than five protein-coding 
genes, seven revTADs contain clusters of functionally-related protein-coding genes: 3 revTADS on chr11 
harbor 61 genes encoding olfactory receptors; 3 revTADs on chr19 harbor 31 genes encoding zinc finger 
proteins; and one revTAD on chr20 contains eight beta-defensins’ genes. Importantly, the expression of genes 
residing within the same TAD appears somewhat correlated and some TADs tend to contain predominantly 
actively transcribed genes while others have mostly repressed genes (Cavalli and Misteli, 2013; Gibcus and 
Dekker, 2013; Nora et al., 2012). Collectively, these results suggest that observed enrichment of HSGRL 
placements in specific genomic regions may facilitate the enhanced precision of regulatory functions in human 
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genomes by targeting TADs harboring relatively few protein-coding genes and/or TADs containing clusters of 
functionally-related protein-coding genes, thus preferentially affecting insulated regulatory networks governing 
selected key developmental events.  
Recently reported results of proximity placement analyses of human-specific NANOG-binding sites 
(HSNBS) revealed their associations with coding genes governing physiological development and functions of 
nervous and cardiovascular systems, embryonic development, behavior, as well as development of a diverse 
spectrum of pathological conditions (Glinsky, 2015). Here this approach was applied to dissect the expression 
profiles of protein-coding genes implicated in the development of the fetal and adult brain of H.sapiens (Zhang 
et al., 2011) and examine their co-localization patterns with HSNBS in the human genome. During the first step 
of this analysis, a set of 251 genes that are at least 20-fold up- or down-regulated in the neocortex temporal 
lobe of the fetal versus adult human brain has been identified. This set of 251 genes was designated a gene 
expression signature of the human fetal neocortex temporal lobe. It was of interest to ascertain the expression 
changes of these genes, if any, in the neocortex, the newest part of human brain, and in the prefrontal 
complex, which is implicated in complex cognitive behavior, compared with non-neocortical regions. 
Expression of two-third of genes comprising the 251-gene expression signature of the human fetal neocortex 
temporal lobe is significantly different in the neocortex compared with non-neocortical regions of human brain 
and gene expression profiles of these genes in neocortex and prefrontal cortex are highly concordant (Figure 
12). Of note, 78% of genes differentially regulated in the neocortex versus non-neocortical regions manifest 
significant changes of expression in the prefrontal cortex versus non-neocortical regions of human brain as 
well. Remarkably, 92.6% of genes differentially regulated in both fetal versus adult brain and neocortex versus 
non-neocortical regions exhibit the same direction of expression changes, that is genes that are up-regulated 
in the fetal brain remain up-regulated in the neocortex and genes that are down-regulated in the fetal brain 
remain down-regulated in the neocortex (Figure 12). Thus, a majority of genes (60%) that acquired most 
dramatic expression changes in the human fetal neocortex temporal lobe appears to retain for many years the 
significance of expression changes acquired in the embryo and maintain highly concordant expression profiles 
in the neocortex and prefrontal cortex regions of adult human brain. Investigation of the placement enrichment 
pattern of HSNBS located near these neocortex/prefrontal cortex-associated genes revealed the most 
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significant enrichment of HSNBS placement at the genomic distances less than 1.5 Mb with a sharp peak of 
the enrichment p value at the distance of 1.5 Mb (Supplemental Figure S7), suggesting that HSNBS may play 
a role in regulation of expression of these genes during embryogenesis.  
These observations prompted the detailed analysis of all 12,885 genes, expression of which is 
significantly different in the human fetal neocortex temporal lobe compared with the adult brain ((Zhang et al., 
2011), and examine their expression in the neocortex and prefrontal cortex regions of the adult human brain. 
Remarkably, the analysis of these fetal neocortex temporal lobe-associate genes revealed that expression of 
4,958 genes is significantly different in the neocortex compared with non-neocortical regions of adult human 
brain and gene expression profiles of these genes in neocortex and prefrontal cortex are highly concordant 
(Figure 12). These results demonstrate that a very large number of genes, consisting of ~25% of all protein-
coding genes in the human genome, acquires in embryo significant expression changes, which are stably 
maintained throughout the embryogenesis, infancy, and the adulthood as a highly concordant gene expression 
profile in the human fetal neocortex temporal lobe as well as in the neocortex and prefrontal cortex regions of 
adult human brain. It provides a compelling argument that gene expression profiles characteristic of the critical 
brain regions, which are essential for development of unique to human cognitive and behavioral functions, are 
established to a significant degree during the embryogenesis, retained for many years of human development, 
and maintained in the adulthood. In agreement with this idea, there is an increased enrichment of 5hmC at 
intragenic regions that are already hyper-hydroxymethylated at the fetal stage during human frontal cortex 
development, demonstrating that adult patterns of genic 5hmC in the frontal cortex are already evident in the 
immature fetal brain (Lister et al., 2013). In the human brain, transcriptional activity is associated with 
intragenic 5hmC enrichment and adult 5hmC patterns for cell type-specific genes appear established in utero; 
in contrast, loss of 5hmC enrichment is associated with developmentally coupled transcriptional down 
regulation of gene expression (Lister et al., 2013).  
Recent experiments discovered that that there is a strikingly accelerated recruitment of new, 
evolutionary young genes during the early development of human brain leading to the increased expression of 
a significantly larger proportion of young genes in fetal or infant brains of humans compared with mouse 
(Zhang et al., 2011). Next, the detailed analysis of the evolutionary age of genes comprising the 4,958-gene 
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expression signature of the neocortex/prefrontal cortex regions of human brain was carried-out. To this end, all 
4,958 genes were segregated into thirteen sub-groups based on their respective evolutionary age, ranging 
from 0 (oldest genes) to 12 (youngest genes) as previously defined by Zhang et al. (2011). The gene 
expression enrichment factors were calculated for each individual evolutionary age sub-group by comparisons 
of corresponding gene age-associated distribution metrics, which were derived from the analysis of gene age-
associated distribution profiles of all 19,335 genes interrogated in gene expression profiling experiments and 
12,885 genes with expression changes significantly different in fetal versus adult brain. The resulting values for 
each evolutionary age sub-group of genes were normalized to the corresponding numerical values obtained for 
all genes within the corresponding set. The results of these analyses revealed that the relative enrichment 
factors of evolutionary young genes are higher compared to evolutionary older counterparts, which appears to 
be associated exclusively with the fraction of up-regulated genes of the 4,958-gene signature of the 
neocortex/prefrontal cortex regions of human brain (Figure 12).  
Next, the placement enrichment analysis of HSNBS located in close proximity to the genomic 
coordinates of the 4,958 genes was performed. In these experiments, the estimates of two different placement 
enrichment metrics were computed.  The numerical values of the first metric is based on the quantitation of 
genes residing within the genomic distance of 1.5 Mb or less from the nearest HSNBS (Figure 12). The 
threshold of 1.5 Mb was chosen based on the quantitative definition of the genomic distance associated with 
the most statistically significant enrichment of HSNBS placement near neocortex/prefrontal cortex associated 
genes (Supplemental Figure S7). The numerical values of the second metric is based on the quantitation of 
genes residing within and outside of the common TAD with HSNBS (Figure 12). In both experimental settings, 
the corresponding placement enrichment values for each sub-group of genes were compared to the values 
calculated for two control gene sets: 447 genes that are not expressed in the human brain and 357 expressed 
unbiased genes, i.e., genes that are uniformly expressed in human brain and do not manifest statistically 
significant differences of expression. Results of these analyses were highly consistent regardless of the utilized 
placement enrichment metrics: it appears that placements of HSNBS favors the evolutionary younger genes of 
sub-groups 7-12 compared with the evolutionary older genes or genes that are not expressed in the human 
brain (Figure 12). It is important to mention that all genes comprising both control gene sets were assigned to 
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the evolutionary age groups 7-12, thus excluding the possibility that placement enrichment differences are due 
to genes of the control gene sets being belong to the evolutionary older genes.  
Collectively, these data are highly consistent with the idea that HSNBS may have contributed to the 
establishment during the embryogenesis of the genome-wide expression changes characteristic of neocortex 
and prefrontal cortex regions of human brain, which are retained as a highly concordant 4,958-gene 
expression signature for many years of human development and maintained in the adulthood. The validity of 
this idea was further explored utilizing the Ingenuity Pathway Analysis software (http://www.ingenuity.com/ ) to 
identify and analyze possible developmental and pathophysiological regulatory networks comprising of 
HSNBS-associated genes, which appear implicated in development of human neocortex and prefrontal cortex 
regions. The Ingenuity software identified two main candidate regulatory networks and predicted five potential 
top regulators and eight their immediate target genes (Figure 13). Of note, seven of eight immediate target 
genes of the top five putative upstream regulators were also identified as regulatory elements of the two main 
networks, which are marked by the five-pointed stars in the Figure 13. One exception is the INSM1 and 
NEUROD1 genes that appear to form an interconnected and highly biologically significant axis, which plays a 
crucial role in m -cell functions via cooperating interactions of INSM1, 
NEUROD1, and FOXA2 genes and combinatorial binding of INSM1, NEUROD1, and FOXA2 proteins to 
regulatory DNA sequences (Jia et al., 2015). Furthermore, the Insm1 gene is required for proper differentiation 
of all types of endocrine cells in the anterior pituitary gland, including pituitary cells producing thyroid-
stimulating hormone, follicle-stimulating hormone, melanocyte-stimulating hormone, adrenocorticotrope 
hormone, growth hormone and prolactin (Welcker et al., 2013). Because it has been previously demonstrated 
that Insm1 gene is required for development and differentiation of endocrine cells in the pancreas, intestine 
and adrenal gland (Gierl et al., 2006; Wildner et al., 2008), it has been defined as the essential pan-endocrine 
transcription factor (Welcker et al. (2013).  
One of the intriguing features seemingly connecting these networks is that some genes identified as 
potential targets within one network appear within another network as the regulatory hubs, which are marked 
as the blue five-pointed stars in the Figure 13. This observation suggests that these networks are 
interconnected by the positive feedback regulatory loops, which appear designed to support the sustained 
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networks’ activity. The largest network is governed by the NANOG and POU5F1 proteins, which are also 
identified as potential targets of the second regulatory network. The VEGFC and KDR genes appear as the 
main regulatory hubs of the second putative regulatory network, within which the NANOG and POU5F1 are 
depicted as potential target genes (Figure 13). Conversely, the VEGFC and KDR genes were identified as the 
putative targets of the regulatory network governed by the NANOG and POU5F1 proteins (Figure 13).  
Taken together, the results of this analysis support the hypothesis that during embryogenesis the 
NANOG and POU5F1 proteins initiate the gene expression changes characteristic of neocortex and prefrontal 
cortex regions of human brain, which are discernable as a highly concordant 4,958-gene expression signature. 
At the later stages of brain development and functioning during infancy and transition to adulthood, the VEGFC 
and its receptor KDR may be responsible, in part, for maintenance and sustained activity of the fetal gene 
expression program in the neocortex/prefrontal cortex regions. This conclusion opens attractive opportunities 
for targeted pharmacological interventions using small molecule agonists and/or antagonists of the 
VEGFC/KDR axis in vivo.  
 
Placement enrichment analysis of HSNBS near genes encoding the protein partners of the NANOG-
centered protein interaction network in embryonic stem cells 
One of the key mechanisms by which NANOG delivers its critical regulatory functions in ESC is the formation 
of protein-protein complexes with numerous protein partners, which are designated collectively as the NANOG 
interactome (Wang et al, 2006; Wu et al, 2006; Liang et al, 2008; Costa et al, 2013; Gagliardi et al., 2013). 
Recent high-definition analysis of physically interacting proteins in ESC using an improved affinity purification 
protocol expanded the NANOG interactome to more than 130 proteins (Gagliardi et al., 2013), many of which 
are components of large multi-subunit complexes involved in chromatin remodeling. Placement enrichment 
analysis identifies 58 genes encoding protein-protein interaction partners of NANOG that are located in close 
proximity to HSNBS defined by the 1.5 Mb placement enrichment metric. Genetic components of the multi-
subunit chromatin remodeling complex NuRD appear most significantly overrepresented among genes 
encoding NANOG-interacting proteins: genes encoding ten of twelve NuRD complex protein subunits (83%) 
are located in close proximity to HSNBS (Figure 13). Notably, 27 of 58 genes encoding protein partners of 
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NANOG that are located near HSNBS have been previously identified as the components of the POU5F1 
(OCT4)-centered protein interaction network in ESC (van den Berg et al., 2011). Significantly, the efficient 
association in the ESC nucleus of both POU5F1 (OCT4) and NANOG proteins with all twelve proteins 
comprising known subunits of the classical NuRD complex has been documented (van den Berg et al., 2011; 
Gagliardi et al., 2013), which indicates that association of both NANOG and POU5F1 proteins with classical 
NuRD complex may constitute an important mechanism of their biological activity in ESC.  
Collectively, the result of these analyses strongly argue that genes encoding proteins that physically 
interact with both NANOG and POU5F1 in the ESC nucleus may represent functionally-relevant targets of the 
HSGRL-associated regulatory networks. Genetic components of the classical multi-subunit chromatin 
remodeling complex NuRD seem particularly relevant in this regard and they should constitute the primary 
candidates for the follow-up structural-functional analyses and mechanistic experiments aiming to dissect their 
roles in human brain development and functions. Consistent with this hypothesis, recent experiments directly 
implicated the NuRD chromatin remodeling complex in establishing synaptic connectivity in the rodent brain 
(Yamada et al., 2014) and in directing the timely and stable peripheral nerve myelination by Schwann cells in 
mice (Hung et al., 2012). Furthermore, significant age-associated decline of expression in dentate gyrus sub-
region of the hippocampus of one of the NuRD complex subunits, RbAp48 (RBBP4), was mechanistically 
connected with the age-related memory loss in humans (Pavlopoulos et al., 2013).  
 
Discussion 
Genome-wide proximity placement analyses of 10,598 DNA sequences representing four distinct families of 
HSGRL identified a small fraction of TADs in the human genome, which manifest a statistically significant 
accumulation of HSGRL compared to the expected values estimated based on a random distribution model. 
This set of TADs, termed rapidly-evolving in humans TADs (revTADs), acquired the maximum enrichment 
levels of 16-fold for HARs; 17-fold for hESC-FHSRRs; 50-fold for HSTFBS; and 88-fold for DHS-FHSRRs (p < 
0.0001 in all instances; Table 1). Follow-up analyses of sixty revTADs, which were defined based on the 
enrichment of HARs and HSTFBS, revealed that all reported to date HSGRL and human-specific epigenetic 
signatures associated with embryonic development appear significantly enriched within the revTAD boundaries 
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(Table 2). One of the features of revTADs was revealed by the correlation analyses: placements of different 
types of HSTFBS manifest significant positive correlations, whereas placements of HARs and HSTFBS exhibit 
inverse correlation profiles (Figure 1). A majority of revTADs in human genome tend to harbor a small number 
of coding genes: 65% of revTADs contain five or less protein-coding genes (Supplemental Figure S8), among 
which eight revTADs harbor just one protein-coding gene and two revTADs contain only non-coding RNA 
genes. Several revTADs contain large clusters of functionally-related protein-coding genes: three revTADS on 
chr11 harbor 61 genes encoding olfactory receptors; three consecutively-spaced revTADs on chr19 harbor 31 
genes encoding zinc finger proteins; and one revTAD on chr20 contains eight beta-defensins’ genes. Overview 
of the RNAseq data documented two other features of revTADs: i) clearly discernable tissue-specific patterns 
of non-coding RNA expression (Supplemental Figure S8); and ii) prominent presence of non-coding RNA 
transcripts in human brain (Supplemental Figure S9).  
Correlation screens of proximity placement patterns of different HSGRL residing within the revTADs 
revealed markedly distinct correlation profiles of individual members of HSGRL families and recombination 
rates within the host revTADs. These analyses readily distinguish placement patterns of HARs and HSTFBS: 
revTADs having high recombination scores tend to accumulate large numbers of HARs while revTADs with low 
recombination scores harbor high numbers of HSTFBS (Figure 2). Consistent with the requirements of DNA 
strand interactions and strand invasion for the recombination process, significant direct correlations were 
observed between recombination scores and intra-chromosomal contacts within revTADs (Figure 2). 
Therefore, placements of HARs and HSTFBS within revTADs appear associated with distinct molecular 
processes. Placement of HARs within revTADs exhibits significant positive correlation with high recombination 
rates (Figure 2), which seems to connect the biogenesis of HARs with recombination mechanisms. In contrast, 
significant inverse correlation between HSTFBS placement and recombination rates as well as location of 99% 
of HSTFBS within TE – derived DNA sequences (Glinsky, 2015) strongly implicate TE activity in the biogenesis 
of HSTFBS. Since HARs by definition are located within highly evolutionary conserved DNA sequences, 
results of these analyses suggest that molecular mechanisms driving the emergence of regulatory loci evolved 
by exaptation of ancestral DNA (Cotney et al., 2013; Villar et al., 2015) may be associated with meiotic 
recombination as well.  
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One of the notable features of potential mechanistic significance is the association of hESC-enriched 
enhancers and SEs with HSGRL (Table 3). Taking into account that there are ~4,000 HSTFBS in the hESC 
genome (Glinsky et al., 2015) and nearly 60% of HARs overlap at least one of the common markers of 
enhancers in human cells (Capra et al., 2013), it seems logical to propose that creation of new enhancer 
elements leading to increasing density of conventional enhancers in selected genomic regions is one of the 
key events defining the increasing genomic complexity as the main direction of evolution of GRNs. Consistent 
with this idea, there are significant direct correlations between the placements within TADs of HARs and 
hESC-enriched enhancers (Figure 3), indicating that there is an apparent trend of the placement preference of 
HARs within TADs harboring hESC-enriched enhances. It follows, that higher density of conventional 
enhancers would increase the probability of local structural transitions of chromatin architecture to SEs and 
SEDs, provided other local structural requirements are in place or co-evolved (see below). In agreement with 
this model, there are 3-fold more SEs in the hESC genome compared with the mESC and the median size of 
hESC SEs is significantly larger (Figure 4).  
Concomitantly, marked changes of TAD structural features in the hESC genome compared with mESC 
were observed, which are particularly striking for revTADs. Genome-wide, there are 42% more TADs in the 
hESC genome and the median size of hESC TADs is significantly smaller (Figure 4). These changes of TAD 
structural features remain consistent when the corresponding comparisons were made between the similar in 
size individual human and mouse chromosomes (Figure 4), indicating that hESC genome contains the 
increased number of the predominantly smaller size TADs. Consistent with these observations, comparisons of 
the high-resolution 3D maps of human and mouse genomes, which were recently obtained by Rao et al. (2014) 
using in situ Hi-C at a resolution range of 1 – 5 Kb, revealed that there are ~3-fold more contact domains 
formed by the concomitantly increased numbers of long-range chromatin loops in the human GM12878 B-cell 
lymphoblasts compared with the mouse CH12 B-cell lymphoblasts (Rao et al., 2014).  
In the hESC genome, structural changes of the revTADs seem particularly evident: 32% of revTADs 
are located within primate-specific genomic regions and the remaining revTADs appear evolved via 
mechanisms of boundary crossing, domain mergers, and creation of new boundaries within larger TADs of 
orthologous mouse sequences. Collectively, this dramatic changes of the regulatory infrastructure of 
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interphase chromatin can be explained by the model of convergence of TAD and SED architecture (Figure 6). 
According to this model, the high density of conventional enhancers increases the likelihood of transition to 
larger in size SE structures, formation of new SEDs, and increasing segmentation of genomic regions into 
insulated regulatory neighborhoods of large SED/small TAD structures. Consistent with this model, significant 
correlations were observed between the size of TADs and genomic span of hESC SEs residing within TADs 
(Figure 5A). There are significant direct correlations between the revTAD sizes and the numbers of hESC-
enriched enhancers residing within revTADs (Figure 5B). Genome-wide, the highly significant direct 
correlation was observed between the size of TADs and the number of hESC-enriched enhancers located 
within TADs (Figure 5C).  
In addition to enabling the creation of new enhancer elements, increasing density of conventional 
enhancers, and facilitating transition to SE structures, potential mechanisms of HSGRL-mediated effects on 
principal regulatory structures of interphase chromatin are likely involve emergence of overlapping 
CTCF/cohesin sites and LMNB1-binding sites as well as continuing insertion of Alu clusters near the putative 
DNA bending sites (Figures 6 & 7). Collectively, the ensemble of these structural changes facilitated by the 
targeted placements and retention of HSGRL at specific genomic locations would enable the emergence of 
new SED structures and remodeling of existing TADs to drive evolution of GRNs (Figure 6). Presented models 
of dynamic transitions of the interphase chromatin principal regulatory structures are in accord with the results 
of recent high-resolution in situ Hi-C experiments demonstrating that human genomes are partitioned into 
contact domains consisting of ~10,000 loops accommodating functional links between enhancers and 
promoters (Rao et al., 2014). Consistent with the idea that chromatin loops frequently demarcate the 
boundaries of contact domains, anchors at the loop bases typically occur at the contact domain boundaries 
and involve binding of two CTCF/cohesin sites in a convergent orientation with the asymmetric binding motifs 
of interacting sites aligned to face each other (Rao et al., 2014).  
Compelling evidence of conservation in individual human genomes of different families of HSGRL 
(Marnetto et al., 2014; Glinsky, 2015; Figure 8; Supplemental Figure S4) are in accord with the hypothesis of 
their putative functional role in defining human-specific phenotypes. Observations of highly consistent patterns 
of significant direct correlations between conservation profiles of distinct seemingly unrelated HSGRL 
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sequences in individual human genomes were observed (Figure 8C and Supplemental Figure S4) suggest 
that HSGRL conservation patterns reflect intrinsic features of the individual human genome, integration of 
which can help to assess the overall capacity of a genome to create and retain HSGRL.  
The potential practical utility of the outlined here concepts are illustrated by building the working models 
of NANOG, POU5F1, and POU3F2 super-enhancers’ domains and associated TAD structures in the hESC 
genome (Figures 9-11; Supplemental Figures S5, S6). Combination of the utility functions of the UCSC 
Genome Browser and GEM principles (Figure 6) facilitated visualization of key structural elements of potential 
functional significance within each model of putative SED structures (Figures 7; 9-10; Supplemental Figures 
S5; S6). Utilizing structural-functional guidance derived from these models, conserved profiles and uniquely 
distinct patterns of H3K27ac peaks’ distribution within the NANOG locus-associated genomic region in 43 
types of human cells and tissues were inferred (Figure 11).  
Putative regulatory consequences of targeted placements of HSGRL on expression of protein-coding 
genes were assessed during the analysis of expression profiles of protein-coding genes implicated in the 
development of the fetal and adult brain (Zhang et al., 2011). These analyses indicate that HSNBS may have 
contributed to the establishment during the embryogenesis of the genome-wide expression changes 
characteristic of neocortex and prefrontal cortex regions of human brain, which are retained as a highly 
concordant 4,958-gene expression signature for many years of human development and maintained 
throughout the adulthood (Figure 12). The follow-up Ingenuity pathway analysis confirmed that NANOG and 
POU5F1 proteins are most likely candidates to initiate the gene expression changes characteristic of neocortex 
and prefrontal cortex regions of human brain (Figure 13), which are discernable as a highly concordant 4,958-
gene expression signature. At the later stages of brain development and function during infancy and transition 
to adulthood, the VEGFC and its receptor KDR may be responsible, in part, for maintenance and sustained 
activity of the fetal gene expression program in the neocortex/prefrontal cortex regions. 
Strikingly, placement enrichment analysis of HSNBS near genes encoding the protein partners of the 
NANOG-centered protein interaction network in embryonic stem cells identified ten genes encoding protein 
subunits of the classical NuRD multi-subunit chromatin remodeling complex as the candidate principal genomic 
regulatory elements, activity of which appears preferentially targeted by insertions of HSRGL. Importantly, all 
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these regulatory proteins were previously identified as the protein-protein interactions partners of both NANOG 
and POU5F1 (OCT4) proteins in the hESC nucleus (van den Berg et al., 2011; Gagliardi et al., 2013), thus, 
supporting the idea that activities of NANOG and POU5F1 proteins via engagement of the classical NuRD 
multi-subunit chromatin remodeling complex play a central role in defining key human-specific elements of 
gene expression changes during the embryonic development of human brain. 
 
Concluding remarks 
Chromosomes can be viewed as the physical conduits of genetic information enabling its secure storage, 
maintenance, transfer, and efficient translation into a diverse spectrum of specific phenotypes. To a large 
degree all these processes are facilitated by the linear code of DNA sequences and enabled by the chromatin 
structures defining a 3D architecture of interphase chromosomes, which can be considered collectively as the 
chromatin folding code. Present analyses indicate that increasing regulatory complexity in human genomes 
associated with targeted placements of thousands HSGRL has major effect on the principal regulatory 
structures of interphase chromatin, namely TADs, SEs, and SEDs. One of the principal creative events in this 
continuing chromatin domain architecture remodeling process is the HSGRL-enabled emergence of new 
enhancer elements, increasing density of which would increase the probability of structural transition from 
conventional enhancers to novel SEs and formation of new SEDs. Significantly, presence of conserved and/or 
newly created overlapping CTCF/cohesin-binding sites flanking novel SEs is the essential requirement for the 
formation of functional SEDs. This continuous process involves continuing removal of old and creation of new 
TFBS through multiple trial-and-error events enabled by retrotransposition, cytosine MADE, and 
recombination. Furthermore, present analyses suggest that these HSGRL-associated changes of the nuclear 
regulatory architecture may facilitate the enhanced precision of regulatory interactions between enhancers and 
target genes within reconstructed insulated SED neighborhoods and rewired TAD networks. Taken together, 
these observations imply that convergence of TAD and SED architectures, which is exemplified by concomitant 
processes of increasing both quantity and size of SEDs and the increasing number and size reduction of 
TADs, is one of the main directions of the interphase chromatin structural changes during the structural 
evolution of genomic regulatory networks.  
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 Comparisons of estimates of time periods required for creation of enhancers and SEs (Table 6) with 
recently reported estimates of enhancers’ half-lives and mean-lifetimes (Villar et al., 2015), which were 
estimated at 296 and 427 hundred million years, respectively, seem to indicate that new enhancer elements 
are created at a markedly faster pace during evolution compared with their decay time span. This marked 
dichotomy of time period requirements for new enhancers’ creation versus enhancers’ decay provides an 
underlying mechanism for increasing genomic complexity as a major trend during evolution of genomic 
regulatory networks. A vast majority of distinct classes of regulatory elements in the hESC genome appears 
created on conserved DNA sequences (Table 6; Supplemental Figure S3), suggesting that exaptation of 
ancestral DNA constitutes a main mechanism of creation of new regulatory sequences in the human genome. 
This conclusion is highly congruent with recent reports describing exaptation of ancestral DNA as a 
mechanism of creation of human-specific enhancers active in embryonic limb (Cotney et al., 2013) and as a 
prevalent mechanism of recently evolved enhancers’ creation during the mammalian genome evolution (Villar 
et al., 2015). Taken together with results of the present analyses, these observations seem to support the 
hypothesis that meiotic recombination is the predominant mechanism responsible for creation of new 
regulatory loci, since exaptation of ancestral DNA appears to generate overall many more recently evolved 
regulatory elements than can be attributed to the repeat-driven expansion mechanisms.  
It has been suggested that evolution of enhancers may represent an example of evolution of 
evolvability (Duque and Sinha, 2012), according to which a genotypic feature evolves not due to its functional 
effect, but due to its effect on the ability of DNA to evolve more quickly (Wagner and Altenberg, 1996). In this 
context, the regulatory balance of HAT and HDAC activities at specific genomic locations as well as the 
performance of enzymatic systems regulating cytosine recovery/methyl-cytosine deamination cycles and DNA 
recombination processes may play a major role during the evolution of regulatory DNA sequences and 
emergence of GRNs controlling unique to human phenotypes. Critical experimental and clinical assessments 
of potential therapeutic opportunities for pharmacological interventions targeting these enzymatic systems and 
functions of VEGFC/KDR axis would be of immediate interest.  
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Materials and Methods 
Data Sources and Analytical Protocols 
Solely publicly available datasets and resources were used for this analysis as well as methodological 
approaches and a computational pipeline validated for discovery of primate-specific gene and human-specific 
regulatory loci (Tay et al., 2009; Kent, 2002; Schwartz et al., 2003; Capra et al., 2013; Marnetto et al., 2014; 
Glinsky, 2015). The analysis is based on the University of California Santa Cruz (UCSC) LiftOver conversion of 
the coordinates of human blocks to corresponding non-human genomes using chain files of pre-computed 
whole-genome BLASTZ alignments with a minMatch of 0.95 and other search parameters in default setting 
(http://genome.ucsc.edu/cgi-bin/hgLiftOver). Extraction of BLASTZ alignments by the LiftOver algorithm for a 
human query generates a LiftOver output “Deleted in new”, which indicates that a human sequence does not 
intersect with any chains in a given non-human genome. This indicates the absence of the query sequence in 
the subject genome and was used to infer the presence or absence of the human sequence in the non-human 
reference genome. Human-specific regulatory sequences were manually curated to validate their identities and 
genomic features using a BLAST algorithm and the latest releases of the corresponding reference genome 
databases for time periods between April, 2013 and June, 2015.  
Genomic coordinates of 3,127 topologically-associating domains (TADs) in hESC; 6,823 hESC-
enriched enhancers; 6,322 conventional and 684 super-enhancers (SEs) in hESC; 231 SEs and 197 SEDs in 
mESC were reported in the previously published contributions (Dixon et al., 2012; Xie et al., 2013; Hnisz et al., 
2013; Whyte et al., 2013; Dowen et al., 2014). The primary inclusion criterion for selection of the human-
specific genomic regulatory loci (HSGRL) analyzed in this contribution was the fact that they were identified in 
human cells lines and primary human tissues whose karyotype were defined as “normal”. The following four 
HSGRL families comprising of 10,598 individual regulatory DNA sequences were analyzed in this study: 1) 
Human accelerated regions (HARs; Capra et al., 2013); 2) Human-specific transcription factor-binding sites 
(HSTFBS; Glinsky, 2015); 3) hESC-derived fixed human-specific regulatory regions (hESC-FHSRR; Marnetto 
et al., 2014); 4) DNase hypersensitive sites-derived fixed human-specific regulatory regions (DHS-FHSRR; 
Marnetto et al., 2014). The number of HSGRL placed within a given TAD was computed for every TAD in the 
hESC genome and the HSGRL placement enrichment was calculated as the ratio of observed values to 
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expected values estimated from a random distribution model at the various cut-off thresholds. Datasets of 
NANOG-, POU5F1-, and CTCF-binding sites and human-specific TFBS in hESCs were reported previously 
(Kunarso et al., 2010; Glinsky, 2015) and are publicly available. RNA-Seq datasets were retrieved from the 
UCSC data repository site (http://genome.ucsc.edu/; Meyer et al., 2013) for visualization and analysis of cell 
type-specific transcriptional activity of defined genomic regions. A genome-wide map of the human methylome 
at single-base resolution was reported previously (Lister et al., 2009; 2013) and is publicly available 
(http://neomorph.salk.edu/human_methylome). The histone modification and transcription factor chromatin 
immunoprecipitation sequence (ChIP-Seq) datasets for visualization and analysis were obtained from the 
UCSC data repository site (http://genome.ucsc.edu/; Rosenbloom et al., 2013). Genomic coordinates of the 
RNA polymerase II (PII)-binding sites, determined by the chromatin integration analysis with paired end-tag 
sequencing (ChIA-PET) method, were obtained from the saturated libraries constructed for the MCF7 and 
K562 human cell lines (Li et al., 2012). Genome-wide maps of interactions with nuclear lamina, defining 
genomic coordinates of human and mouse lamin-associated domains (LADs), were obtained from previously 
published and publicly available sources (Guelen et al., 2008; Peric-Hupkes et al., 2010). The density of TF-
binding to a given segment of chromosomes was estimated by quantifying the number of protein-specific 
binding events per 1-Mb and 1-kb consecutive segments of selected human chromosomes and plotting the 
resulting binding site density distributions for visualization. Visualization of multiple sequence alignments was 
performed using the WebLogo algorithm (http://weblogo.berkeley.edu/logo.cgi ). Consensus TF-binding site 
motif logos were previously reported (Kunarso et al., 2010; Wang et al., 2012; Ernst and Kellis, 2013).  
The quantitative limits of proximity during the proximity placement analyses were defined based on 
several metrics. One of the metrics was defined using the genomic coordinates placing HSGRL closer to 
putative target protein-coding or lncRNA genes than experimentally defined distances to the nearest targets of 
50% of the regulatory proteins analyzed in hESCs (Guttman et al., 2011). For each gene of interest, specific 
HSGRL were identified and tabulated with a genomic distance between HSGRL and a putative target gene that 
is smaller than the mean value of distances to the nearest target genes regulated by the protein-coding TFs in 
hESCs. The corresponding mean values for protein-coding and lncRNA target genes were calculated based on 
distances to the nearest target genes for TFs in hESC reported by Guttman et al. (2011). In addition, the 
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proximity placement metrics were defined based on co-localization within the boundaries of the same TADs 
and the placement enrichment pattern of HSNBS located near the 251 neocortex/prefrontal cortex-associated 
genes, which identified the most significant enrichment of HSNBS placement at the genomic distances less 
than 1.5 Mb with a sharp peak of the enrichment p value at the distance of 1.5 Mb (Supplemental Figure S7).  
The comprehensive database of expression profiles of protein-coding genes implicated in the 
development of the fetal and adult brain of H. sapiens was obtained from the previously published contribution 
(Zhang et al., 2011). Analysis of the evolutionary age of genes comprising the 4,958-gene expression 
signature of the neocortex/prefrontal cortex regions of human brain was carried-out by segregating genes into 
thirteen sub-groups based on their respective evolutionary age, ranging from 0 (oldest genes) to 12 (youngest 
genes) as previously defined by Zhang et al. (2011). The gene expression enrichment factors were calculated 
for each individual evolutionary age sub-group by comparisons of corresponding gene age-associated 
distribution metrics, which were derived from the analysis of gene age-associated distribution profiles of all 
19,335 genes interrogated in gene expression profiling experiments and 12,885 genes with expression 
changes significantly different in fetal versus adult brain. The resulting values for each evolutionary age sub-
group of genes were normalized to the corresponding numerical values obtained for all genes within the 
corresponding set.  
The assessment of conservation of HSGRL in individual genomes of 3 Neanderthals, 12 Modern 
Humans, and the 41,000-year old Denisovan genome (Reich et al., 2010; Meyer et al., 2012) was carried-out 
by direct comparisons of corresponding sequences retrieved from individual genomes and the human genome 
reference database (http://genome.ucsc.edu/Neandertal/ ). Direct access to the specific Genome Browser 
tracks utilized for analyses and visualization: 
http://genome.ucsc.edu/cgi-bin/hgTracks?db=hg18&position=chr10%3A69713986-
69714099&hgsid=393865029_yg7UixUE4a4awjjTahns4KTPkIl1 . 
Recombination rates were downloaded from the HapMap Project (The International Hapmap 
Consortium, 2007) and the numbers of DNA segments with the recombination rates of 10 cM/Mb or greater 
were counted. This threshold exceeds ~10-fold the mean intensity of recombination rates in telomeric regions, 
which were identified as the regions with the higher recombination rates in the human genome. It is well known 
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that over large genomic scales, recombination rates tend to be higher in telomeric as compared to centromeric 
chromosomal regions. In telomeric regions, the mean detected hotspot spacing is 90 kb and the mean intensity 
(total rate across the hotspot) per hotspot is 0.115 cM, whereas for centromeric regions the mean spacing is 
123 kb and the mean intensity is 0.070 cM (The International Hapmap Consortium, 2007).  
 
Statistical Analyses of the Publicly Available Datasets 
All statistical analyses of the publicly available genomic datasets, including error rate estimates, background 
and technical noise measurements and filtering, feature peak calling, feature selection, assignments of 
genomic coordinates to the corresponding builds of the reference human genome, and data visualization, were 
performed exactly as reported in the original publications and associated references linked to the 
corresponding data visualization tracks (http://genome.ucsc.edu/). Any modifications or new elements of 
statistical analyses are described in the corresponding sections of the Results. Statistical significance of the 
Pearson correlation coefficients was determined using GraphPad Prism version 6.00 software. The 
significance of the differences in the numbers of events between the groups was calculated using two-sided 
Fisher’s exact and Chi-square test, and the significance of the overlap between the events was determined 
using the hypergeometric distribution test (Tavazoie et al., 1999).  
 
 
 
 
 
 
 
 
 
 
 
 43 
 
Supplemental Information 
Supplemental information includes Supplemental Table S1, Supplemental Figures S1–S8 and can be found 
with this article online.  
 
Author Contributions 
This is a single author contribution. All elements of this work, including the conception of ideas, formulation, 
and development of concepts, execution of experiments, analysis of data, and writing of the paper, were 
performed by the author.  
 
Acknowledgements 
This work was made possible by the open public access policies of major grant funding agencies and 
international genomic databases and the willingness of many investigators worldwide to share their primary 
research data. I would like to thank my colleagues for their valuable critical contributions during the informal 
review and formal peer review process of this work.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
 
References 
Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, 
G.T., and McVean, G.A.; 1000 Genomes Project Consortium. 2012. An integrated map of genetic variation 
from 1,092 human genomes. Nature 491: 56–65. 
Adami, C., Ofria, C., Collier, T.C. 2000. Evolution of biological complexity. Proc Natl Acad Sci U S A. 97: 4463-
8. 
Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine SE. 2008. Active Alu 
retrotransposons in the human genome. Genome Res. 18:1875-83.  
Bird C, Stranger B, Liu M, Thomas D, Ingle C, Beazley C, Miller W, Hurles M, Dermitzakis E. 2007. Fast-
evolving noncoding sequences in the human genome. Genome Biol. 8(6): R118. 
Capra, J.A., Erwin, G.D., McKinsey, G., Rubenstein, J.L., Pollard, K.S. 2013. Many human accelerated regions 
are developmental enhancers. Philos Trans R Soc Lond B Biol Sci. 368 (1632): 20130025.  
Cavalli, G., and Misteli, T. 2013. Functional implications of genome topology. Nat. Struct. Mol. Biol. 20: 290–
299. 
Chen X, Xu H, Yuan P, Fang F, Huss M, et al. 2008. Integration of external signaling pathways with the core 
transcriptional network in embryonic stem cells. Cell 133: 1106–1117. 
Chimpanzee Sequencing and Analysis Consortium. 2005 Initial sequence of the chimpanzee genome and 
comparison with the human genome. Nature 437: 69–87.  
Cotney, J., Leng, J., Yin, J., Reilly, S.K., DeMare, L.E., Emera, D., Ayoub, A.E., Rakic, P., and Noonan, J.P. 
(2013). The evolution of lineage-specific regulatory activities in the human embryonic limb. Cell 154: 185–196. 
Costa Y, Ding J, Theunissen TW, Faiola F, Hore TA, Shliaha PV, Fidalgo M, Saunders A, Lawrence M, 
Dietmann S, Das S, Levasseur DN, Li Z, Xu M, Reik W, Silva JC, Wang J. 2013. NANOG-dependent function 
of TET1 and TET2 in establishment of pluripotency. Nature 495: 370–374.  
Cotney, J., Leng, J., Yin, J., Reilly, S.K., DeMare, L.E., Emera, D., Ayoub, A.E., Rakic, P., Noonan, J.P. 2013. 
The evolution of lineage-specific regulatory activities in the human embryonic limb. Cell 154: 185-96. 
Dixon, J.R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J.S., and Ren, B. 2012. Topological 
domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485: 376–380. 
 45 
 
Dowen J.M., Fan Z.P., Hnisz D., Ren G., Abraham B.J., Zhang L.N., Weintraub A.S., Schuijers J., Lee T.I., 
Zhao K., Young R.A. 2014. Control of cell identity genes occurs in insulated neighborhoods in mammalian 
chromosomes. Cell 159: 374–387. 
Ernst, J., and Kellis, M. 2013. Interplay between chromatin state, regulator binding, and regulatory motifs in six 
human cell types. Genome Res. 23, 1142-1154. 
Fazzio TG, Huff JT, Panning B. 2008. An RNAi screen of chromatin proteins identifies Tip60- p400 as a 
regulator of embryonic stem cell identity. Cell 134: 162–174. 
Fu Q, Li H, Moorjani P, Jay F, Slepchenko SM, Bondarev AA, Johnson PL, Aximu-Petri A, Prüfer K, de Filippo 
C, Meyer M, Zwyns N, Salazar-García DC, Kuzmin YV, Keates SG, Kosintsev PA, Razhev DI, Richards MP, 
Peristov NV, Lachmann M, Douka K, Higham TF, Slatkin M, Hublin JJ, Reich D, Kelso J, Viola TB, Pääbo S. 
Genome sequence of a 45,000-year-old modern human from western Siberia. Nature. 2014; 514: 445-9. 
Freudenberg, J., Fu, Y.H., Ptácek, L.J. 2007. Human recombination rates are increased around accelerated 
conserved regions - evidence for continued selection? Bioinformatics 23: 1441-3. 
Gagliardi A, Mullin NP, Ying Tan Z, Colby D, Kousa AI, Halbritter F, Weiss JT, Felker A, Bezstarosti K, Favaro 
R, Demmers J, Nicolis SK, Tomlinson SR, Poot RA, Chambers I. 2013. A direct physical interaction between 
Nanog and Sox2 regulates embryonic stem cell self-renewal. EMBO J 32: 2231-2247.  
Gibcus, J.H., and Dekker, J. 2013. The hierarchy of the 3D genome. Mol. Cell 49: 773–782. 
Gierl, M. S., Karoulias, N., Wende, H., Strehle, M. and Birchmeier, C. 2006. The zinc-finger factor Insm1 (IA-1) 
is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev. 20: 2465-
2478. 
Glinsky, G.V. 2015. Transposable elements and DNA methylation create in embryonic stem cells human-
specific regulatory sequences associated with distal enhancers and non-coding RNAs. Genome Biol Evol. 7, 
1432-1454.  
Gräff J1, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, Su SC, 
Samiei A, Joseph N, Haggarty SJ, Delalle I, Tsai LH. 2012. An epigenetic blockade of cognitive functions in the 
neurodegenerating brain. Nature 483: 222-6. 
Green RE et al. 2010. A draft sequence of the Neanderthal genome. Science; 328, 710–722.  
 46 
 
Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, 
Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH. 2009. HDAC2 negatively regulates memory 
formation and synaptic plasticity. Nature 459: 55-60. 
Guelen, L., Pagie, L., Brasset, E., Meuleman, W., Faza, M.B., Talhout, W., Eussen, B.H., de Klein, A., 
Wessels, L., de Laat, W., and van Steensel, B. (2008). Domain organization of human chromosomes revealed 
by mapping of nuclear lamina interactions. Nature 453, 948-951.  
Guttman, M., Donaghey, J., Carey, B.W., Garber, M., Grenier, J.K., Munson, G., Young, G., Lucas, A.B., Ach, 
R., Bruhn, L., Yang, X., Amit, I., Meissner, A., Regev, A., Rinn, J.L., Root, D.E., and Lander, E.S. (2011). 
lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477:295-300. 
Hagelkruys A, Lagger S, Krahmer J, Leopoldi A, Artaker M, Pusch O, Zezula J, Weissmann S, Xie Y, Schöfer 
C, Schlederer M, Brosch G, Matthias P, Selfridge J, Lassmann H, Knoblich JA, Seiser C. 2014. A single allele 
of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog. 
Development. 141: 604-16.  
Hanson JE, Deng L, Hackos DH, Lo SC, Lauffer BE, Steiner P, Zhou Q. 2013. Histone deacetylase 2 cell 
autonomously suppresses excitatory and enhances inhibitory synaptic function in CA1 pyramidal neurons. J 
Neurosci. 33: 5924-9. 
Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre´, V., Sigova, A.A., Hoke, H.A., and Young, R.A. 
(2013). Super-enhancers in the control of cell identity and disease. Cell 155, 934–947. 
Hou, C., Li, L., Qin, Z.S., and Corces, V.G. (2012). Gene density, transcription, and insulators contribute to the 
partition of the Drosophila genome into physical domains. Mol. Cell 48, 471–484. 
Huda A, Mariño-Ramírez L, Landsman D, Jordan IK. 2009. Repetitive DNA elements, nucleosome binding and 
human gene expression. Gene 436:12-22. 
Hung H, Kohnken R, Svaren J. 2012. The nucleosome remodeling and deacetylase chromatin remodeling 
(NuRD) complex is required for peripheral nerve myelination. J Neurosci. 32: 1517-27.  
Jamaladdin, S., Kelly, R.D., O'Regan, L., Dovey, O.M., Hodson, G.E., Millard, C.J., Portolano, N., Fry, A.M., 
Schwabe, J.W., Cowley, S.M. 2014. Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell 
division and the pluripotency of embryonic stem cells. Proc Natl Acad Sci U S A 111: 9840-9845.  
 47 
 
Jia S, Ivanov A, Blasevic D, Müller T, Purfürst B, Sun W, Chen W, Poy MN, Rajewsky N, Birchmeier C. 2015. 
Insm1 cooperates with Neurod1 and Foxa2 to maintain mature pancreatic β-cell function. EMBO J. 34: 1417-
33. 
Jin, F., Li, Y., Dixon, J.R., Selvaraj, S., Ye, Z., Lee, A.Y., Yen, C.A., Schmitt, A.D., Espinoza, C.A., Ren, B. 
2013. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 503: 290-
4. 
Katzman, S., Capra J.A., Haussler, D., Pollard ,K.S. 2011. Ongoing GC-biased evolution is widespread in the 
human genome and enriched near recombination hot spots. Genome Biol Evol. 3, 614-26. 
Kent, W.J. 2002. BLAT - the BLAST-like alignment tool. Genome Res. 12, 656-664.  
King MC, Wilson AC. 1975. Evolution at two levels in humans and chimpanzees. Science 188: 107-16. 
Kostka, D., Hubisz M.J., Siepel A., Pollard K.S. 2012. The role of GC-biased gene conversion in shaping the 
fastest evolving regions of the human genome. Mol Biol Evol. 3, 1047-57. 
Kraushaar, D.C., Jin, W., Maunakea, A., Abraham, B., Ha, M., Zhao, K. 2013. Genome-wide incorporation 
dynamics reveal distinct categories of turnover for the histone variant H3.3. Genome Biology 14: R121.  
Kunarso, G., Chia, N.Y., Jeyakani, J., Hwang, C., Lu, X., Chan, Y.S., Ng, H.H., and Bourque, G. (2010). 
Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet. 
42, 631-634.  
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, 
FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, 
McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, 
Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, 
Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, 
Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, 
Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, 
 48 
 
Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston 
RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, 
Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer 
JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, 
Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher 
E, Frazier M, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860- 
921. 
Lee W, Mun S, Kang K, Hennighausen L, Han K. 2015. Genome-wide target site triplication of Alu elements in 
the human genome. Gene 561:283-91. 
Li, G., Ruan, X., Auerbach, R.K., Sandhu, K.S., Zheng, M., Wang, P., Poh, H.M., Goh, Y., Lim, J., Zhang, J., 
Sim, H.S., Peh, S.Q., Mulawadi, F.H., Ong, C.T., Orlov, Y.L., Hong, S., Zhang, Z., Landt, S., Raha, D., 
Euskirchen, G., Wei, C.L., Ge, W., Wang, H., Davis, C., Fisher-Aylor, K.I., Mortazavi, A., Gerstein, M., 
Gingeras, T., Wold, B., Sun, Y., Fullwood, M.J., Cheung, E., Liu, E., Sung, W.K., Snyder, M., and Ruan, Y. 
2012. Extensive promoter-centered chromatin interactions provide a topological basis for transcription 
regulation. Cell 148, 84-98. 
Li, Y., Huang, W., Niu, L., Umbach, D.M., Covo, S., Li, L. 2013. Characterization of constitutive CTCF/cohesin 
loci: a possible role in establishing topological domains in mammalian genomes. BMC Genomics. 14: 553. 
Li X, Li L, Pandey R, Byun JS, Gardner K, et al. 2012. The histone acetyltransferase MOF is a key regulator of 
the embryonic stem cell core transcriptional network. Cell Stem Cell 11: 163–178. 
Liang J, Wan M, Zhang Y, Gu P, Xin H, Jung SY, Qin J, Wong J, Cooney AJ, Liu D, Songyang Z. 2008. Nanog 
and Oct4 associate with unique transcriptional repression complexes in embryonic 
stem cells. Nat Cell Biol 10: 731–739.  
Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery, J.R., Lee, L., Ye, Z., 
Ngo, Q.M., Edsall, L., Antosiewicz-Bourget, J., Stewart, R., Ruotti, V., Millar, A.H., Thomson, J.A., Ren, B., and 
 49 
 
Ecker, J.R. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. 
Nature 462, 315-322. 
Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz 
MD, Yu M, Tonti-Filippini J, Heyn H, Hu S, Wu JC, Rao A, Esteller M, He C, Haghighi FG, Sejnowski TJ, 
Behrens MM, Ecker JR. 2013. Global epigenomic reconfiguration during mammalian brain development. 
Science.341, 1237905. 
Meyer, M., Kircher, M., Gansauge, M.T., Li, H., Racimo, F., Mallick, S., Schraiber, J.G., Jay, F., Prüfer, K., de 
Filippo, C., Sudmant, P.H., Alkan, C., Fu, Q., Do, R., Rohland, N., Tandon, A., Siebauer, M., Green, R.E., Bryc, 
K., Briggs, A.W., Stenzel, U., Dabney, J., Shendure, J., Kitzman, J., Hammer, M.F., Shunkov, M.V., 
Derevianko, A.P., Patterson, N., Andrés, A.M., Eichler, E.E., Slatkin, M., Reich, D., Kelso, J., Pääbo, S. (2012). 
A high-coverage genome sequence from an archaic Denisovan individual. Science. 338, 222-226. 
Meyer, L.R., Zweig, A.S., Hinrichs, A.S., Karolchik, D., Kuhn, R.M., Wong, M., Sloan, C.A., Rosenbloom, K.R., 
Roe, G., Rhead, B., Raney, B.J., Pohl, A., Malladi, V.S., Li, C.H., Lee, B.T., Learned, K., Kirkup, V., Hsu, F., 
Heitner, S., Harte, R.A., Haeussler, M., Guruvadoo, L., Goldman, M., Giardine, B.M., Fujita, P.A., Dreszer, 
T.R., Diekhans, M., Cline, M.S., Clawson, H., Barber, G.P., Haussler, D., and Kent, W.J. 2013. The UCSC 
Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 41, D64-69. 
Morales ME, White TB, Streva VA, DeFreece CB, Hedges DJ, Deininger PL. 2015. The contribution of Alu 
elements to mutagenic DNA double-strand break repair. PLoS Genet. 11:e1005016. 
Ng, H.H., and Surani, M.A. 2011. The transcriptional and signalling networks of pluripotency. Nat. Cell Biol. 13, 
490–496. 
Nora, E.P., and Heard, E. 2010. Chromatin structure and nuclear organization dynamics during X-chromosome 
inactivation. Cold Spring Harb. Symp. Quant. Biol. 75: 333–344. 
Nora, E.P., Lajoie, B.R., Schulz, E.G., Giorgetti, L., Okamoto, I., Servant, N., Piolot, T., van Berkum, N.L., 
Meisig, J., Sedat, J., et al. 2012. Spatial partitioning of the regulatory landscape of the X-inactivation centre. 
Nature 485: 381–385. 
 50 
 
Pang, Z. P., Yang, N., Vierbuchen, T., Ostermeier, A., Fuentes, D. R., Yang, T. Q., Citri, A., Sebastiano, V., 
Marro, S., Sudhof, T. C., Wernig, M.2011.  Induction of human neuronal cells by defined transcription factors. 
Nature 476: 220-223.  
Pavlopoulos E, Jones S, Kosmidis S, Close M, Kim C, Kovalerchik O, Small SA, Kandel ER. 2013. Molecular 
mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med. 5: 200ra115. 
Peric-Hupkes, D., Meuleman, W., Pagie, L., Bruggeman, S.W., Solovei, I., Brugman, W., Gräf, S., Flicek, P., 
Kerkhoven, R.M., van Lohuizen, M., Reinders, M., Wessels, L., and van Steensel, B. 2010. Molecular maps of 
the reorganization of genome-nuclear lamina interactions during differentiation. Mol. Cell. 38, 603-613. 
Pollard KS, Salama SR, Lambert N, et al. (16 co-authors). 2006. An RNA gene expressed during cortical 
development evolved rapidly in humans. Nature 443: 167–172. 
Prabhakar S, Noonan JP, Paabo S, Rubin EM. 2006. Accelerated evolution of conserved noncoding 
sequences in humans. Science 314(5800): 786. 
Prabhakar S, Visel A, Akiyama JA, et al. (13 co-authors). 2008. Human specific gain of function in a 
developmental enhancer. Science 321(5894): 1346–1350. 
Prüfer K, Munch K, Hellmann I, Akagi K, Miller JR, Walenz B, Koren S, Sutton G, Kodira C, Winer R, Knight 
JR, Mullikin JC, Meader SJ, Ponting CP, Lunter G, Higashino S, Hobolth A, Dutheil J, Karakoç E, Alkan C, 
Sajjadian S, Catacchio CR, Ventura M, Marques-Bonet T, Eichler EE, André C, Atencia R, Mugisha L, Junhold 
J, Patterson N, Siebauer M, Good JM, Fischer A, Ptak SE, Lachmann M, Symer DE, Mailund T, Schierup MH, 
Andrés AM, Kelso J, Pääbo S. 2012. The bonobo genome compared with the chimpanzee and human 
genomes. Nature 486: 527-31. 
Prüfer K, Racimo F, Patterson N, Jay F, Sankararaman S, Sawyer S, Heinze A, Renaud G, Sudmant PH, de 
Filippo C, Li H, Mallick S, Dannemann M, Fu Q, Kircher M, Kuhlwilm M, Lachmann M, Meyer M, Ongyerth M, 
Siebauer M, Theunert C, Tandon A, Moorjani P, Pickrell J, Mullikin JC, Vohr SH, Green RE, Hellmann I, 
Johnson PL, Blanche H, Cann H, Kitzman JO, Shendure J, Eichler EE, Lein ES, Bakken TE, Golovanova LV, 
Doronichev VB, Shunkov MV, Derevianko AP, Viola B, Slatkin M, Reich D, Kelso J, Pääbo S. 2014. The 
complete genome sequence of a Neanderthal from the Altai Mountains. Nature 505: 43-9. 
 51 
 
Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, Sanborn AL, Machol I, Omer AD, 
Lander ES, Aiden EL. 2014. A 3D map of the human genome at kilobase resolution reveals principles of 
chromatin looping. Cell 159: 1665-80. 
Reich, D., Green, R.E., Kircher, M., Krause, J., Patterson, N., Durand, E.Y., Viola, B., Briggs, A.W., Stenzel, 
U., Johnson, P.L., Maricic, T., Good, J.M., Marques-Bonet, T., Alkan, C., Fu, Q., Mallick, S., Li, H., Meyer, M., 
Eichler, E.E., Stoneking, M., Richards, M., Talamo, S., Shunkov, M.V., Derevianko, A.P., Hublin, J.J., Kelso, J., 
Slatkin, M., Pääbo, S. (2010). Genetic history of an archaic hominin group from Denisova Cave in Siberia. 
Nature. 468, 1053-1060. 
Rosenbloom, K.R., Sloan, C.A., Malladi, V.S., Dreszer, T.R., Learned, K., Kirkup, V.M., Wong, M.C., Maddren, 
M., Fang, R., Heitner, S.G., Lee, B.T., Barber, G.P., Harte, R.A., Diekhans, M., Long, J.C., Wilder, S.P., Zweig, 
A.S., Karolchik, D., Kuhn, R.M., Haussler, D., and Kent, W.J. 2013. ENCODE data in the UCSC Genome 
Browser: year 5 update. Nucleic Acids Res. 41, D56-63. 
Rizzon, C., Marais, G., Gouy, M., Biémont, C. 2002. Recombination rate and the distribution of transposable 
elements in the Drosophila melanogaster genome. Genome Res. 12: 400–407. 
Schmidt, D., Schwalie, P.C., Wilson, M.D., Ballester, B., Gonçalves, A., Kutter, C., Brown, G.D., Marshall, A., 
Flicek, P., and Odom, D.T. 2012. Waves of retrotransposon expansion remodel genome organization and 
CTCF binding in multiple mammalian lineages. Cell 148:335–348. 
Schwartz, S., Kent, W.J., Smit, A., Zhang, Z., Baertsch, R., Hardison, R.C., Haussler, D., and Miller, W. 2003. 
Human-mouse alignments with BLASTZ. Genome Res. 13, 103–107.  
Seitan VC, Faure AJ, Zhan Y, McCord RP, Lajoie BR, Ing-Simmons E, Lenhard B, Giorgetti L, Heard E, Fisher 
AG, Flicek P, Dekker J, Merkenschlager M. 2013. Cohesin-based chromatin interactions enable regulated 
gene expression within preexisting architectural compartments. Genome Res. 23: 2066–2077. 
Sexton, T., Yaffe, E., Kenigsberg, E., Bantignies, F., Leblanc, B., Hoichman, M., Parrinello, H., Tanay, A., and 
Cavalli, G. 2012. Three-dimensional folding and functional organization principles of the Drosophila genome. 
Cell 148: 458–472. 
Smallwood, A., and Ren, B. 2013. Genome organization and long-range regulation of gene expression by 
enhancers. Curr. Opin. Cell Biol. 25: 387–394. 
 52 
 
Sofueva S, Yaffe E, Chan WC, Georgopoulou D, Vietri Rudan M, Mira-Bontenbal H, Pollard SM, Schroth GP, 
Tanay A, Hadjur S.. 2013. Cohesin-mediated interactions organize chromosomal domain architecture. The 
EMBO J. 32: 3119–3129. 
Tark-Dame M, Jerabek H, Manders EM, Heermann DW, van Driel R. 2014. Depletion of the chromatin looping 
proteins CTCF and cohesin causes chromatin compaction: insight into chromatin folding by polymer modelling. 
PLoS Comput Biol. 10: e1003877.  
Tay, S.K., Blythe, J., and Lipovich, L. 2009. Global discovery of primate-specific genes in the human genome. 
Proc. Natl. Acad. Sci. USA 106, 12019-12024. 
The International Hapmap Consortium. 2007. A second generation human haplotype map of over 3.1 million 
SNPs. Nature 449: 851–861. 
Tavazoie, S., Hughes, J.D., Campbell, M.J., Cho, R.J., and Church, GM. 1999. Systematic determination of 
genetic network architecture. Nat. Genet. 22, 281-285. 
Villar D, Berthelot C, Aldridge S, Rayner TF, Lukk M, Pignatelli M, Park TJ, Deaville R, Erichsen JT, Jasinska 
AJ, Turner JM, Bertelsen MF, Murchison EP, Flicek P, Odom DT. 2015. Enhancer evolution across 20 
mammalian species. Cell 160: 554-66. 
Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. 2006. A protein interaction network 
for pluripotency of embryonic stem cells. Nature 444: 364–368.  
Wang, J., Zhuang, J., Iyer, S., Lin, X., Whitfield, T.W., Greven, M.C., Pierce, B.G., Dong, X., Kundaje, A., 
Cheng, Y., Rando, O.J., Birney, E., Myers, R.M., Noble, W.S., Snyder, M., and Weng, Z. 2012. Sequence 
features and chromatin structure around the genomic regions bound by 119 human transcription factors.  
Genome Res. 22, 1798-1812. 
Wapinski OL, Vierbuchen T, Qu K, Lee QY, Chanda S, Fuentes DR, Giresi PG, Ng YH, Marro S, Neff NF, 
Drechsel D, Martynoga B, Castro DS, Webb AE, Südhof TC, Brunet A, Guillemot F, Chang HY, Wernig M. 
2013. Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell 155: 621-35. 
Welcker JE, Hernandez-Miranda LR, Paul FE, Jia S, Ivanov A, Selbach M, Birchmeier C. 2013. Insm1 controls 
development of pituitary endocrine cells and requires a SNAG domain for function and for recruitment of 
histone-modifying factors. Development. 140: 4947-58.  
 53 
 
Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I., and Young, 
R.A. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 
153, 307–319. 
Wildner, H., Gierl, M. S., Strehle, M., Pla, P. and Birchmeier, C. 2008. Insm1 (IA-1) is a crucial component of 
the transcriptional network that controls differentiation of the sympatho-adrenal lineage. Development 135: 
473-481. 
Wu Q, Chen X, Zhang J, Loh YH, Low TY, Zhang W, Zhang W, Sze SK, Lim B, Ng HH. 2006. Sall4 interacts 
with Nanog and cooccupies Nanog genomic sites in embryonic stem cells. J Biol Chem 281: 24090–24094.  
Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, Whitaker JW, Tian S, Hawkins RD, Leung D, Yang 
H, Wang T, Lee AY, Swanson SA, Zhang J, Zhu Y, Kim A, Nery JR, Urich MA, Kuan S, Yen CA, Klugman S, 
Yu P, Suknuntha K, Propson NE, Chen H, Edsall LE, Wagner U, Li Y, Ye Z, Kulkarni A, Xuan Z, Chung WY, 
Chi NC, Antosiewicz-Bourget JE, Slukvin I, Stewart R, Zhang MQ, Wang W, Thomson JA, Ecker JR, Ren B.. 
2013. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 153: 1134-48. 
Yamada T, Yang Y, Hemberg M, Yoshida T, Cho HY, Murphy JP, Fioravante D, Regehr WG, Gygi SP, 
Georgopoulos K, Bonni A. 2014. Promoter decommissioning by the NuRD chromatin remodeling complex 
triggers synaptic connectivity in the mammalian brain. Neuron. 83: 122-34. 
Young, R.A. 2011. Control of the embryonic stem cell state. Cell 144: 940–954. 
Zhang, Y.E, Landback, P., Vibranovski, M.D., Long, M. 2011. Accelerated recruitment of new brain 
development genes into the human genome. PLoS Biol 9(10): e1001179. 
Zhong X, Jin Y. 2009. Critical roles of coactivator p300 in mouse embryonic stem cell differentiation and Nanog 
expression. J Biol Chem 284: 9168–9175. 
Zuin J, Dixon JR, van der Reijden MI, Ye Z, Kolovos P, Brouwer RW, van de Corput MP, van de Werken HJ, 
Knoch TA, van IJcken WF, Grosveld FG, Ren B, Wendt KS. 2014. Cohesin and CTCF differentially affect 
chromatin architecture and gene expression in human cells. Proc Natl Acad Sci USA 111: 996-1001. 
 
 
 
 54 
 
Figure Legends 
Figure 1. Correlation screens revealed distinct patterns of associations between HARs and TFBS residing 
within the rapidly-evolving in human Topologically Associating Domains (revTADs).  
A. UCSC Genome Browser view of the revTAD on human chr6 harboring 10 Human Accelerated Regions, 
HARs (red bars), 10 hESC-enriched enhancers (black bars), 52 primate-specific TFBS for NANOG (26 sites), 
POU5F1 (10 sites), CTCF (26 sites), and 72 recombination hotspots with recombination rates at least 10 
cM/Mb (blue bars). Genomic coordinates of POU3F2 super-enhancer domain in the hESC genome is depicted 
by the horizontal arrow.  
B. Direct correlations between the numbers of primate-specific CTCF-binding sites and HSTFBS residing 
within the 60 revTADs (top left panel). Note that when primate-specific CTCF-binding sites were segregated 
into human-specific and non-human primate specific sub-groups, correlation coefficients are stronger for 
human-specific CTCF-binding sites (top right and bottom left panels) and weaker for non-human primate-
specific CTCF-binding sites (bottom right panel).  
C. Inverse correlations between the numbers of primate-specific CTCF-binding sites and HARs residing within 
the 60 revTADs (top left panel). Note that when primate-specific CTCF-binding sites were segregated into 
human-specific and non-human primate specific sub-groups, correlation coefficients are stronger for human-
specific CTCF-binding sites (top right panel) and weaker for non-human primate-specific CTCF-binding sites 
(bottom right panel). Bottom left panel shows the inverse correlation between the numbers of human-specific 
NANOG-binding sites and HARs. 
D. The inverse correlation between the numbers of HSTFBS and HARs residing within the 36 revTADs each of 
which contains both HSTFBS and HARs (top left panel). Top right panel shows the inverse correlation between 
the numbers of HSTFBS and HARs residing within the set of 60 revTADs (see Table 2 and text for details). 
 
Figure 2. Distinct correlation profiles of HSGRL and recombination rates within the revTADs distinguish 
placement patterns of HARs and HSTFBS.  
A, B. Visualization of the placement distribution patterns of HARs (low positioned red bars), recombination 
hotspots, RHs (blue bars), and HSTFBS (high positioned red bars with designations of TF names) within the 
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revTADs. Note that revTADs containing high numbers of RHs (192 to 402 RHs) tend to harbor higher numbers 
of HARs (15 to 24 HARs) and no HSTFBS (figures in the panel A). In contrast, revTADs containing 
intermediate (69 to 94 RHs) or low (2 RHs) numbers of RHs tend to harbor intermediate and low numbers of 
HARs and multiple HSTFBS (figures in the panel B). 
C. Inverse correlations between the numbers of RHs (designated as the recombination scores) and numbers of 
HSTFBS within the revTADs. Correlation profiles are shown for recombination scores (RS) and HSTFBS (top 
left panel), RS and HSNBS (top right panel), and RS and human-specific CTCF-binding sites (bottom left 
panel). In contrast, lack of significant correlation was recorded for RS and the numbers of non-human primate-
specific CTCF-binding sites (bottom right panel).  
D. Significant direct correlations were observed between the RS and the numbers of HARs (top left panel) and 
the RS and cumulative numbers of intrachromosomal contacts (top left panel) within the revTADs. Bottom two 
panels show the correlation profiles between the median RS values and median values of intrachromosomal 
contacts (bottom left panel) and the median numbers of HARs and HSTFBS (bottom left panel) for the four 
sub-groups of revTADs that were segregated into quartiles based on the values of the cumulative numbers of 
intrachromosomal contacts observed within the individual revTADs (Jin et al., 2013). Note that the median RS 
value for the revTADs placed in the top quartile based on the quantity of observed intrachromosomal 
interactions was 40-fold greater compared to the median RS value of the revTADs assigned to the bottom 
quartile (bottom left panel). 
 
Figure 3. Genome-wide associations between the number of HARs and the quantity of hESC-enriched 
enhancers located within TADs.  
A. Direct correlation between the numbers of HARs and hESC-enriched enhancers located within the individual 
revTADs.  
B-D. In the hESC genome, TADs segregated into sub-groups with increasing numbers of HARs contain 
concomitantly higher proportion of hESC-enriched enhancer-harboring TADs compared with TADs without 
hESC enhancers. The fractions of TADs with and without hESC enhancers are shown for a total of 3,062 TADs 
(hg19 release of human reference genome database) in the hESC genome (B), for 1,135 TADs harboring 
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2,609 HARs (C), for 2,075 TADs containing 6,703 hESC-enriched enhancers (D). In the figure (D) the average 
numbers of hESC-enriched enhancers are shown for sub-groups of TADs harboring 0; 1; 2; and at least 5 
HARs. P values designate the statistical significance of the differences of the hESC enhancer numbers 
between the neighboring sub-groups of TADs. Calculations of the HAR numbers located within TADs were 
performed after converting the genomic coordinates of 3,127 TADs (Dixon et al., 2012) from the hg18 to hg19 
release of the human reference genome database using the LiftOver algorithm.  
 
Figure 4. Markedly distinct structural features of SEs and TADs in genomes of human and mouse ESCs.  
A. Size distribution analyses revealed significantly increased size of SEs and decreased size of TADs in the 
hESC genome compared with mouse. Top two panels show the median sizes of SEs (top left panel) and TADs 
(top right panel) sorted in a descending order based on individual TAD sizes and segregated into ten sub-
groups at 10% increments. Bottom two panels show the median (bottom left panel) and average (bottom right 
panel) sizes of TADs for individual chromosomes of human and mouse ESC genomes. Note that median sizes 
of TADs on 17 of 20 (85%) chromosomes in the hESC genome (except chr7, chr13, and chr14) are smaller 
compared to median TAD sizes on chromosomes in the mESC genome.  
B. Numbers of both SEs (top left panel) and TADs (top right panel) are increased in the hESC genome 
compared with mouse. Bottom two panels illustrate that numbers of TADs are decreased in differentiated cells 
compared to ESC both in humans (bottom left panel) and mice (bottom right panel). 
 
Figure 5. Placements of hESC enhancers and HARs within TADs are directly correlated with the size of TADs 
in the hESC genome.  
A. Significant direct correlations between the size of TADs and SE’s span defined as a number of bp between 
the two most distant SEs located within a given TAD in the hESC genome (top two panels). Top left panel 
shows a correlation profile between the size of 504 TADs and genomic span of 642 SEs located within TADs. 
Top right panel shows a correlation profile between the size of 103 TADs harboring at least two SEs and 
genomic span of 241 SEs residing within TADs. Percentiles within shaded areas indicate the percent of TADs 
containing HSGRL within a designated set, which increases concomitantly with the increasing quantity of SEs 
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located within TADs and larger TAD size. Note that similar trends were observed in the mESC genome, 
however, the correlation coefficient values were not statistically significant (bottom two panels).  
B. Patterns of significant direct correlations between the size of 147 revTADs and numbers of hESC-enriched 
enhancers (top left panel) and HARs (top right panel) located within the revTADs. Bottom two panels show the 
profiles of significant correlations between residing within the revTADs hESC-enriched enhancers and HARs 
(direct correlation; bottom left panel) and HSTFBS and HARs (inverse correlation; bottom right panel).  
C. Genome-wide, there is a highly significant direct correlation between the numbers of hESC-enriched 
enhancers located within TADs and the average size of corresponding TADs harboring hESC-enriched 
enhancers. The numbers of hESC-enriched enhancers located within each individual TAD were quantified and 
TADs harboring 0 to 9 enhancers were segregated into subgroups harboring the same numbers of enhancers. 
The numbers of TADs in each subgroup are indicated. Eighty-one TADs harboring ten or more hESC-enriched 
enhancers (range 10-30) were segregated into one subgroup with the average enhancers’ content of 12.5 per 
TAD. The average TAD sizes were computed for each subgroup of TADs and the results were plotted to asses 
the correlation pattern. 
 
Figure 6. A model of genome evolution driven by the increasing complexity of genomic regulatory networks 
(GRNs). It is proposed that evolutionary process occurs within the context of the intrinsic division of 
mammalian genomes into regions of high and low recombination rates that are associated with the low and 
high probabilities of TE insertion and/or retention as well as C/G and A/T alleles’ bias, respectively. According 
to the genome evolution model (GEM), the continuing emergence of new enhancer elements constitutes a 
critical creative event driving the increasing complexity of GRNs in the hESC genome (see text for details). 
Potential mechanisms of HSGRL-mediated effects on principal regulatory structures of interphase chromatin 
involve: I) Creation of new TFBS and novel enhancer elements; II) Increasing density of conventional 
enhancers and facilitating transition to SE structures; III) Emergence of overlapping CTCF/cohesion-binding 
sites and LMNB1-binding sites;  
IV) Continuing insertion of clusters of Alu elements near the putative DNA bending sites (Figure 7). 
Collectively, the ensemble of these structural changes facilitated by the targeted placements and retention of 
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HSGRL at specific genomic locations would enable the emergence of new SED structures and remodeling of 
existing TADs to drive evolution of GRNs. MADE, cytosine methylation associated DNA editing. 
 
Figure 7. Clusters of Alu elements in the vicinity of putative DNA bending sites near the borders of SEDs and 
TADs.  
A. Clusters of Alu elements near the borders of the ID3 SED on chr1:23,878,033-23,894,300 (16,268 bp). 
Dotted lines depict the genomic positions of the overlapping CTCF/cohesin-binding sites, interactions of which 
form the anchor base of the ID3 SED.  
B. Clusters of Alu elements near the NANOG SED left border on chr12:7,864,594-7,869,500 (4,907 bp).  
C. Clusters of Alu elements near the NANOG SED right border on chr12:8,012,400-8,017,400 (5,001 bp).   
Arrows in the figures (B) and )C) point the overlapping CTCF/cohesin-binding sites, interactions between which 
form the anchor base of the NANOG SED.  
Note that clusters of closely-spaced sequences of at least three Alu elements belonging to most ancient AluJ 
(~65 million years old), second oldest AluS (~30 million years old), and currently active modern AluY sub-
families are observed, suggesting that placement and/or retention of Alu elements at these sites were 
occurring for millions of years and continues at the present time (see text for details). 
 
Figure 8. Conservation patterns of HSGRL in individual human genomes.  
Conservation of HSGRL in individual genomes of 3 Neanderthals, 12 Modern Humans, and the 41,000-year 
old Denisovan genome was carried-out by direct comparisons of corresponding sequences retrieved from 
individual genomes and the human genome reference database (http://genome.ucsc.edu/Neandertal/). Full-
length sequence alignments with no gaps of the individual human genome sequences to the corresponding 
sequences in the human genome reference databases were accepted as the evidence of sequence 
conservation in the individual human genome.  
A. Top two panels show conservation patterns of HSGRL located within the revTADs for 57 HARs and 
associated 75 CTCF-binding sites (top left panel); 22 HARs harboring 23 LMNB1-binding sites and 23 LMNB1-
binding sites residing within 22 HARs (top right panel). Bottom two panels show conservation patterns of 90 
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HARs harboring 93 LMB1-binding sites (bottom left panel) and 55 HARs harboring 55 CTCF-binding sites and 
55 CTCF-binding sites located within 55 HARs (bottom right panel).  
B. Top two panels show conservation patterns of 123 HARs associated with 127 high-confidence overlapping 
CTCF/RAD21-binding sites (top left pane) and 127 high-confidence overlapping CTCF/RAD21-binding sites 
associated with 123 HARs (top right panel). Bottom two panels show conservation patterns of 69 
CTCF/RAD21-binding sites conserved in all Neandertals’ genome (bottom left panel) and 152 human-specific 
NANOG-binding sites highly-conserved in individual human genomes (bottom right panel). Note that 
conservation of all HSGRL are consistently at the lowest level in the Neanderthals’ genome, suggesting that 
creation and/or retention rates of HSGRL are enhanced in Modern Humans. However, HSGRL sequences 
manifesting the relatively high conservation levels in the Neanderthals’ genome appear most conserved in the 
individual genomes of Modern Humans as well, including the 41,000-year old Denisovan genome (bottom left 
panel). Sequences of HSGRL with assigned biochemical functions, e.g., specific TFBS or Lamin B1 (LMNB1)-
binding sites, which are residing within HARs exhibit markedly higher conservation levels compared to 
sequences of HARs harboring the corresponding HSGRL. This conclusion remains valid for HSGRL 
sequences with assigned specific biochemical or biological functions that were associated with HARs by 
proximity placement analyses (figures A, B). 
C. Direct correlations of conservation profiles of DNA sequences of distinct HSGRL in individual human 
genomes (top two panels) and markedly different values of genomic fitness scores (GFS) integrating into a 
single numerical value sequence conservation data of 909 HSGRL in individual human genomes (bottom 
panel). Note that values of GFS are inversely correlated with the variation coefficients of GFS values in 
individual human genomes, consistent with the hypothesis that GFS reflects the intrinsic property of an 
individual genome to create and/or retain the HSGRL. 
 
Figure 9. Genomic features of 2D models of individual super-enhancer domains (SEDs) in the hESC genome. 
A. UCSC Genome Browser view of the 2D model of the NANOG super-enhancers’ domain in the hESC 
genome (chr12:7,760,238-7,904,075). Genomic coordinates of two hESC-super-enhancers are depicted by the 
semi-transparent arks; positions of 5 primate-specific NANOG-binding sites are marked by the red arrows; 
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conserved and primate-specific overlapping CTCF/cohesin-binding sites that may be involved in formation of 
the anchors at the SED base are designated; genomic position of the primate-specific region harboring LAD 
sequence is depicted by the brace shape. Note that insertion of the primate-specific LAD sequence down-
stream of the NANOG gene suggests that SED loop is more likely to be formed by folding of the upstream 
chromatin chain toward the nuclear lamina-bound DNA sequence (figure 10).  
B. UCSC Genome Browser view of the POU5F1 super-enhancer domain in the hESC genome 
(chr6:31,212,185-31,272,994). Genomic coordinates of the hESC-super-enhancer are depicted by the semi-
transparent ark; positions of 3 primate-specific and one human-specific NANOG-binding sites are marked by 
the red arrows; conserved and primate-specific overlapping CTCF/cohesin-binding sites that may be involved 
in formation of the anchors at the SED base are designated.  
C. UCSC Genome Browser zoom-in views of the anchor regions at the bases of SEDs are shown. Note that 
the SED anchor regions typically contain two LMNB1-binding sites near the overlapping CTCF/cohesin-binding 
sites, interactions of which secure the chromatin loop formation and segregation of insulated genomic 
neighborhoods of SEDs. These observations suggest that a spatial positioning of SED anchor regions is 
secured by the attachment to the nuclear lamina. 
 
Figure 10. A snap-shot of principal genomic features of the 3D model of the interphase chromatin folding. A 
3D model of spatial positioning of principal regulatory elements of the 2.54 Mb genomic region adjacent to the 
NANOG locus in the hESC genome is shown within the context of the 3 consecutive TADs and 4 boundary 
regions (depicted as blue clouds containing clusters of 3-5 overlapping CTCF/cohesin-binding sites). Positions 
of overlapping CTCF/cohesin-binding sites interactions of which secure the bases of chromatin loops are 
depicted by the yellow-colored donut shapes. Positions of key TFBS, including HSTFBS, are marked by the 
arrows. Attachment regions of blue-colored chromatin chains to the nuclear lamina are depicted by the 
placement of the corresponding segments within red-colored LADs. ED, hESC-enriched enhancers’ domain; 
SED, super-enhancers’ domains; EDs and SEDs are designated by the corresponding names of the protein-
coding genes. Genomic coordinates of TADs, EDs, and SEDs are listed. Inset shows a highly significant direct 
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correlation between the size of TADs and genomic span of hESC-enriched enhancers located within TADs (r = 
0.995; p = 0.0055). 
 
Figure 11. Conserved profiles and uniquely distinct patterns of H3K27ac peaks’ distribution within the NANOG 
locus-associated genomic region in 43 types of human cells and tissues. 
Regional genomic maps of H3K27ac peaks/SE distributions depicting numbers of SEs placed within 3.26 Mb 
genomic region containing four TADs and three TAD boundaries (A) for individual types of human cells and 
tissues against the background of SE distribution profiles within the same region in the hESC genome. Note 
that all individual profiles of SE distributions in human cells and tissues (B, C), which reflect distribution profiles 
of H3K27ac peaks, follow the general pattern of SE distributions established in the hESC genome (figures B & 
C). One of the notable common elements that emerged in many differentiated cells and tissues is the 
appearance of SEs within the genomic regions demarcating TAD boundaries in the hESC genome, suggesting 
that TAD boundaries and TAD structures undergo visible rearrangements in differentiated cells and tissues. 
Erasing the hESC TAD boundaries during differentiation due to appearance of new cell-type specific SEs is 
consistent with observed decreasing numbers of TADs in differentiated cells and tissues (figure 4).   
D, E. Unique patterns of H3K27peaks’/enhancers’ distribution profiles in 43 types of human cells and tissues. 
In figure E, the data set was sorted in descending order of total numbers of enhancers (right Y axis) located 
within the region in each cell and tissue type. The position of hESC within this distribution is shown by the 
dotted line. The names of cells and tissues are listed. See text for details.  
 
Figure 12. Identification and characterization of the 4,958 genes’ expression signature in the human fetal 
neocortex temporal lobe retaining the expression changes acquired in the embryo for many years of human 
brain development and maintaining highly concordant expression profiles in the neocortex and prefrontal 
cortex regions of adult human brain.  
A. Concordant expression profiles of 163 genes with at least 20-fold expression changes in the fetal neocortex 
temporal lobe that also manifest significant expression changes in the neocortex versus non-neocortical 
regions of adult human brain (top right panel). Note that expression changes of these 163 genes are highly 
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concordant in both neocortex and prefrontal cortex regions of adult human brain versus non-neocortical 
regions (top left panel). Bottom two panels show highly concordant expression profiles of 4,958 genes with 
significant expression changes in fetal versus adult human brain and neocortex versus non-neocortical regions 
of adult human brain (bottom right panel) as well as either prefrontal cortex or neocortex versus non-
neocortical regions of adult human brain (bottom left panel).   
B. Analysis of expression enrichment patterns of 4,958 genes suggests a bias toward up-regulation of 
evolutionary young genes and down-regulation of evolutionary old genes. See text for detail.  
C. Placement enrichment analysis of neocortex/prefrontal cortex signature genes near human-specific 
NANOG-binding sites (HSNBS) suggests a bias toward evolutionary young coding genes and genes 
expressed in brain compared with genes that are not expressed in human brain. Bottom right panel shows 
enrichment of co-localization within common TADs for neocortex/prefrontal cortex signature genes and HSNBS 
compared with genes that are not expressed in human brain. 
 
Figure 13. Genomic regulatory networks (GRNs) of human neocortex/prefrontal cortex development and 
functions that are associated with HSNBS and under potential regulatory controls of the classical multi-subunit 
NurD chromatin remodeling complex. 
A. Ingenuity Pathway Analysis of human neocortex/prefrontal cortex signature genes identifies candidate 
GRNs that appear under putative regulatory controls of the NANOG and POU5F1 proteins in embryogenesis 
and seem to transition to regulatory control of the VEGFC and its receptor KDR at the later developmental 
stages and in the adult brain. See text for details.  
B. All 12 proteins comprising the classical multi-subunit NurD chromatin remodeling complex represent protein 
partners of both NANOG-centered and POU5F1-centered protein-protein interaction networks in hESC (van 
den Berg et al., 2011; Gagliardi et al., 2013). Genes encoding 10 of 12 (83%) subunits of the classical multi-
subunit NurD chromatin remodeling complex are located near human-specific NANOG-binding sites in the 
hESC genome. See text for additional details. 
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